Quiver News

$100,000 of NRG ENERGY INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Permitting reform, co-location/data centers, and FCC Docket Number 25-110"

You can find more data on corporate lobbying on Quiver Quantitative.

NRG Insider Trading Activity

NRG insiders have traded $NRG stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $NRG stock by insiders over the last 6 months:

• BRIAN CURCI (Exec VP & General Counsel) has made 0 purchases and 2 sales selling 107,556 shares for an estimated $17,258,059.
• ROBERT J GAUDETTE (Exec VP, NRG Business) sold 45,000 shares for an estimated $7,144,200
• VIRGINIA KINNEY (Exec VP, Chief Admin Officer) sold 20,000 shares for an estimated $3,276,400
• BRUCE CHUNG (EVP & CFO) has made 0 purchases and 3 sales selling 20,000 shares for an estimated $3,148,134.
• DAK LIYANEARACHCHI (Exec VP, Chief Technology Ofc.) sold 10,672 shares for an estimated $1,654,160

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NRG Hedge Fund Activity

We have seen 520 institutional investors add shares of NRG stock to their portfolio, and 507 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 5,202,627 shares (+54.9%) to their portfolio in Q3 2025, for an estimated $842,565,442
• BANCO SANTANDER, S.A. removed 2,206,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $357,261,700
• GOLDMAN SACHS GROUP INC removed 1,832,544 shares (-57.6%) from their portfolio in Q3 2025, for an estimated $296,780,500
• JANE STREET GROUP, LLC removed 1,573,503 shares (-67.0%) from their portfolio in Q3 2025, for an estimated $254,828,810
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,332,394 shares (+85.8%) to their portfolio in Q3 2025, for an estimated $215,781,208
• HOLOCENE ADVISORS, LP removed 1,149,645 shares (-79.6%) from their portfolio in Q3 2025, for an estimated $186,185,007
• LSV ASSET MANAGEMENT removed 1,098,044 shares (-70.7%) from their portfolio in Q3 2025, for an estimated $177,828,225

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NRG Analyst Ratings

Wall Street analysts have issued reports on $NRG in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 01/27/2026
• Wells Fargo issued a "Overweight" rating on 10/28/2025
• Melius Research issued a "Buy" rating on 08/20/2025
• Barclays issued a "Overweight" rating on 08/07/2025

To track analyst ratings and price targets for NRG, check out Quiver Quantitative's $NRG forecast page.

NRG Price Targets

Multiple analysts have issued price targets for $NRG recently. We have seen 9 analysts offer price targets for $NRG in the last 6 months, with a median target of $203.0.

Here are some recent targets:

• Julien Dumoulin-Smith from Jefferies set a target price of $181.0 on 01/27/2026
• Shahriar Pourreza from Wells Fargo set a target price of $206.0 on 01/20/2026
• William Appicelli from UBS set a target price of $211.0 on 12/09/2025
• James Thalacker from BMO Capital set a target price of $195.0 on 11/07/2025
• Stephen Byrd from Morgan Stanley set a target price of $144.0 on 10/28/2025
• Angie Storozynski from Seaport Global set a target price of $202.0 on 10/08/2025
• Andrew Weisel from Scotiabank set a target price of $212.0 on 09/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$390,000 of NATIONAL FUEL GAS COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"LIHEAP, pipeline permitting reform, climate change policy, pipeline safety reauthorization, energy policy (including renewable natural gas and hydrogen), energy choice, natural gas appliances , federal oversight of natural gas use, Energy Star program, pipeline security & cybersecurity, natural gas use in federal facilities, federal tax policy."

You can find more data on corporate lobbying on Quiver Quantitative.

NFG Hedge Fund Activity

We have seen 306 institutional investors add shares of NFG stock to their portfolio, and 255 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AQR CAPITAL MANAGEMENT LLC added 1,087,067 shares (+103.4%) to their portfolio in Q3 2025, for an estimated $100,412,378
• VICTORY CAPITAL MANAGEMENT INC removed 519,704 shares (-42.1%) from their portfolio in Q3 2025, for an estimated $48,005,058
• WATERFORD ADVISORS, LLC removed 299,586 shares (-99.0%) from their portfolio in Q3 2025, for an estimated $27,672,758
• YAUPON CAPITAL MANAGEMENT LP removed 294,684 shares (-62.3%) from their portfolio in Q3 2025, for an estimated $27,219,961
• BLACKROCK, INC. added 257,158 shares (+3.0%) to their portfolio in Q3 2025, for an estimated $23,753,684
• SQUAREPOINT OPS LLC added 250,130 shares (+428.8%) to their portfolio in Q3 2025, for an estimated $23,104,508
• WESTWOOD HOLDINGS GROUP INC added 249,032 shares (+inf%) to their portfolio in Q3 2025, for an estimated $23,003,085

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$22,500 of 908 DEVICES INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY26 CJS Appropriations - Law Enforcement Funding FY26 DOD Appropriations - Air Force and Navy Funding Border Technology Funding Navy and Air Force Technology Funding Law Enforcement Funding"

You can find more data on corporate lobbying on Quiver Quantitative.

MASS Insider Trading Activity

MASS insiders have traded $MASS stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $MASS stock by insiders over the last 6 months:

• JOSEPH H. IV GRIFFITH (Chief Financial Officer) has made 0 purchases and 3 sales selling 10,000 shares for an estimated $80,585.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MASS Hedge Fund Activity

We have seen 47 institutional investors add shares of MASS stock to their portfolio, and 52 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST LIGHT ASSET MANAGEMENT, LLC added 1,442,883 shares (+135.2%) to their portfolio in Q3 2025, for an estimated $12,639,655
• ARK INVESTMENT MANAGEMENT LLC removed 694,506 shares (-26.2%) from their portfolio in Q3 2025, for an estimated $6,083,872
• GM ADVISORY GROUP, LLC removed 487,205 shares (-41.8%) from their portfolio in Q3 2025, for an estimated $4,267,915
• FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 336,584 shares (+125.9%) to their portfolio in Q3 2025, for an estimated $2,948,475
• MARSHALL WACE, LLP removed 209,157 shares (-32.2%) from their portfolio in Q3 2025, for an estimated $1,832,215
• RAYMOND JAMES FINANCIAL INC added 176,616 shares (+2649.5%) to their portfolio in Q3 2025, for an estimated $1,547,156
• D. E. SHAW & CO., INC. removed 160,612 shares (-86.3%) from their portfolio in Q3 2025, for an estimated $1,406,961

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MASS Analyst Ratings

Wall Street analysts have issued reports on $MASS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Leerink Partners issued a "Outperform" rating on 08/05/2025

To track analyst ratings and price targets for MASS, check out Quiver Quantitative's $MASS forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$410,000 of THE MOSAIC COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Critical minerals PERMIT Act (HR3898); Maintaining Cooperative Permitting Act (S. 1014/HR3898) Legal trade remedies Federal tax code"

You can find more data on corporate lobbying on Quiver Quantitative.

MOS Congressional Stock Trading

Members of Congress have traded $MOS stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MOS stock by members of Congress over the last 6 months:

• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MOS Insider Trading Activity

MOS insiders have traded $MOS stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MOS stock by insiders over the last 6 months:

• JODY LYNNE KUZENKO purchased 685 shares for an estimated $17,488

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MOS Hedge Fund Activity

We have seen 358 institutional investors add shares of MOS stock to their portfolio, and 359 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 16,035,052 shares (+76.5%) to their portfolio in Q3 2025, for an estimated $556,095,603
• AQR CAPITAL MANAGEMENT LLC added 7,294,205 shares (+632.6%) to their portfolio in Q3 2025, for an estimated $252,963,029
• BOSTON PARTNERS removed 6,648,109 shares (-89.7%) from their portfolio in Q3 2025, for an estimated $230,556,420
• BANK OF NEW YORK MELLON CORP added 3,894,947 shares (+102.3%) to their portfolio in Q3 2025, for an estimated $135,076,761
• D. E. SHAW & CO., INC. removed 2,909,883 shares (-39.2%) from their portfolio in Q3 2025, for an estimated $100,914,742
• FULLER & THALER ASSET MANAGEMENT, INC. removed 2,217,861 shares (-99.7%) from their portfolio in Q3 2025, for an estimated $76,915,419
• MILLENNIUM MANAGEMENT LLC removed 1,895,347 shares (-76.1%) from their portfolio in Q3 2025, for an estimated $65,730,633

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MOS Analyst Ratings

Wall Street analysts have issued reports on $MOS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 01/12/2026
• Barclays issued a "Overweight" rating on 11/13/2025
• JP Morgan issued a "Overweight" rating on 08/11/2025

To track analyst ratings and price targets for MOS, check out Quiver Quantitative's $MOS forecast page.

MOS Price Targets

Multiple analysts have issued price targets for $MOS recently. We have seen 13 analysts offer price targets for $MOS in the last 6 months, with a median target of $32.0.

Here are some recent targets:

• Michael Sison from Wells Fargo set a target price of $27.0 on 01/23/2026
• Andrew D. Wong from RBC Capital set a target price of $29.0 on 01/20/2026
• Nigel Dally from Morgan Stanley set a target price of $35.0 on 01/14/2026
• Lucas Beaumont from UBS set a target price of $33.0 on 01/12/2026
• Christopher Parkinson from Mizuho set a target price of $28.0 on 12/18/2025
• Benjamin Theurer from Barclays set a target price of $31.0 on 12/09/2025
• Jeffrey Zekaukas from JP Morgan set a target price of $24.0 on 12/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$52,500 of LIGHTBRIDGE CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocate for the adoption of Lightbridges technology for disposition of plutonium from weapons in nuclear power reactors and for the use of their fuel in nuclear powered icebreakers. Advocate for an amendment to the ADVANCE Act."

You can find more data on corporate lobbying on Quiver Quantitative.

LTBR Insider Trading Activity

LTBR insiders have traded $LTBR stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $LTBR stock by insiders over the last 6 months:

• SETH GRAE (President and CEO) has made 0 purchases and 3 sales selling 60,512 shares for an estimated $1,639,152.
• ANDREY MUSHAKOV (EVP, Nuclear Operations) has made 0 purchases and 2 sales selling 42,691 shares for an estimated $981,494.
• LARRY GOLDMAN (CFO) has made 0 purchases and 6 sales selling 51,211 shares for an estimated $886,560.
• SWETA CHAKRABORTY has made 0 purchases and 6 sales selling 29,037 shares for an estimated $481,182.
• JESSE L. FUNCHES has made 0 purchases and 2 sales selling 2,897 shares for an estimated $57,398.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LTBR Hedge Fund Activity

We have seen 70 institutional investors add shares of LTBR stock to their portfolio, and 27 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 578,530 shares (+2541.0%) to their portfolio in Q3 2025, for an estimated $12,270,621
• AMERIPRISE FINANCIAL INC added 563,516 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,952,174
• SCULPTOR CAPITAL LP removed 355,500 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,540,155
• BLACKROCK, INC. added 346,047 shares (+30.2%) to their portfolio in Q3 2025, for an estimated $7,339,656
• CITADEL ADVISORS LLC added 323,688 shares (+905.5%) to their portfolio in Q3 2025, for an estimated $6,865,422
• BNP PARIBAS FINANCIAL MARKETS added 312,605 shares (+168.2%) to their portfolio in Q3 2025, for an estimated $6,630,352
• AROSA CAPITAL MANAGEMENT LP removed 300,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,363,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of BENTLEY SYSTEMS lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Surface transportation reauthorization and appropriations."

You can find more data on corporate lobbying on Quiver Quantitative.

BSY Insider Trading Activity

BSY insiders have traded $BSY stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $BSY stock by insiders over the last 6 months:

• GREGORY S BENTLEY (Executive Chair & President) sold 37,160 shares for an estimated $2,037,575
• THOMAS F TRIMBACK (Chief Accounting Officer) sold 560 shares for an estimated $24,091
• DAVID R. SHAMAN (Chief Legal Officer) sold 400 shares for an estimated $23,700

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BSY Hedge Fund Activity

We have seen 238 institutional investors add shares of BSY stock to their portfolio, and 222 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 2,931,296 shares (+inf%) to their portfolio in Q3 2025, for an estimated $150,903,118
• MANNING & NAPIER ADVISORS LLC added 2,347,598 shares (+inf%) to their portfolio in Q3 2025, for an estimated $120,854,345
• VANGUARD GROUP INC added 1,792,591 shares (+10.7%) to their portfolio in Q3 2025, for an estimated $92,282,584
• AXA S.A. removed 1,545,265 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $79,550,242
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 984,753 shares (+85.8%) to their portfolio in Q3 2025, for an estimated $50,695,084
• PICTET ASSET MANAGEMENT HOLDING SA removed 658,823 shares (-17.8%) from their portfolio in Q3 2025, for an estimated $33,916,208
• BESSEMER GROUP INC added 534,776 shares (+27.4%) to their portfolio in Q3 2025, for an estimated $27,530,268

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BSY Analyst Ratings

Wall Street analysts have issued reports on $BSY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 01/22/2026
• Rosenblatt issued a "Buy" rating on 11/06/2025
• Baird issued a "Outperform" rating on 11/06/2025
• Piper Sandler issued a "Overweight" rating on 11/06/2025
• Oppenheimer issued a "Outperform" rating on 08/07/2025
• Goldman Sachs issued a "Sell" rating on 08/07/2025

To track analyst ratings and price targets for BSY, check out Quiver Quantitative's $BSY forecast page.

BSY Price Targets

Multiple analysts have issued price targets for $BSY recently. We have seen 10 analysts offer price targets for $BSY in the last 6 months, with a median target of $49.5.

Here are some recent targets:

• Daniel Jester from BMO Capital set a target price of $48.0 on 01/22/2026
• Kristen Owen from Oppenheimer set a target price of $53.0 on 01/20/2026
• Clarke Jeffries from Piper Sandler set a target price of $45.0 on 01/13/2026
• Guy Hardwick from Barclays set a target price of $47.0 on 01/12/2026
• Matthew Hedberg from RBC Capital set a target price of $48.0 on 01/05/2026
• Alexei Gogolev from JP Morgan set a target price of $51.0 on 11/06/2025
• Blair Abernethy from Rosenblatt set a target price of $58.0 on 11/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of ENVIRI CORPORATION (FORMERLY HARSCO CORPORATION) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"IIJA reauthorization and appropriations"

You can find more data on corporate lobbying on Quiver Quantitative.

NVRI Insider Trading Activity

NVRI insiders have traded $NVRI stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NVRI stock by insiders over the last 6 months:

• JENNIFER OTT KOZAK (Senior Vice President & CHRO) sold 9,692 shares for an estimated $176,197

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NVRI Hedge Fund Activity

We have seen 92 institutional investors add shares of NVRI stock to their portfolio, and 92 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 4,561,968 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $57,891,373
• PERTENTO PARTNERS LLP added 3,431,188 shares (+inf%) to their portfolio in Q3 2025, for an estimated $43,541,775
• SHAY CAPITAL LLC added 1,940,000 shares (+2939.4%) to their portfolio in Q3 2025, for an estimated $24,618,600
• DAVIDSON KEMPNER CAPITAL MANAGEMENT LP added 1,683,800 shares (+inf%) to their portfolio in Q3 2025, for an estimated $21,367,422
• MILLENNIUM MANAGEMENT LLC added 1,318,833 shares (+4621.0%) to their portfolio in Q3 2025, for an estimated $16,735,990
• SCOPIA CAPITAL MANAGEMENT LP added 953,281 shares (+inf%) to their portfolio in Q3 2025, for an estimated $12,097,135
• HG VORA CAPITAL MANAGEMENT, LLC removed 775,000 shares (-22.1%) from their portfolio in Q3 2025, for an estimated $9,834,750

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$200,000 of CENOVUS US CORPORATION (FKA CENOVUS ENERGY) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Renewable Fuel Standard (RFS) issues relating to the Small Refinery Exemption program, RIN obligations, and Reid Vapor Pressure requirements Issues relating to EPA Refinery Risk Management Plan Issues related to H.R. 1435 / S. 2090 (Preserving Choice in Vehicle Purchases Act) and potential restrictions on consumer purchases of internal combustion engine vehicles Potential impacts of tariffs on energy imports; issues relating to trade"

You can find more data on corporate lobbying on Quiver Quantitative.

CVE Hedge Fund Activity

We have seen 185 institutional investors add shares of CVE stock to their portfolio, and 202 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS added 79,345,506 shares (+291.3%) to their portfolio in Q3 2025, for an estimated $1,348,080,146
• CAPITAL WORLD INVESTORS removed 28,681,373 shares (-15.5%) from their portfolio in Q3 2025, for an estimated $487,296,527
• FIL LTD added 27,283,176 shares (+11827.7%) to their portfolio in Q3 2025, for an estimated $463,541,160
• MILLENNIUM MANAGEMENT LLC removed 20,792,158 shares (-88.1%) from their portfolio in Q3 2025, for an estimated $353,258,764
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 16,885,137 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $286,878,477
• CAPITAL INTERNATIONAL INVESTORS removed 12,045,606 shares (-19.7%) from their portfolio in Q3 2025, for an estimated $204,654,845
• CANADA PENSION PLAN INVESTMENT BOARD removed 10,731,438 shares (-69.1%) from their portfolio in Q3 2025, for an estimated $182,327,131

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CVE Analyst Ratings

Wall Street analysts have issued reports on $CVE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• RBC Capital issued a "Outperform" rating on 11/17/2025
• CIBC issued a "Outperformer" rating on 11/14/2025
• TD Securities issued a "Buy" rating on 09/30/2025

To track analyst ratings and price targets for CVE, check out Quiver Quantitative's $CVE forecast page.

CVE Price Targets

Multiple analysts have issued price targets for $CVE recently. We have seen 5 analysts offer price targets for $CVE in the last 6 months, with a median target of $28.0.

Here are some recent targets:

• Neil Mehta from Goldman Sachs set a target price of $20.0 on 01/02/2026
• Greg Pardy from RBC Capital set a target price of $32.0 on 11/17/2025
• Dennis Fong from CIBC set a target price of $32.0 on 11/14/2025
• Menno Hulshof from TD Securities set a target price of $28.0 on 09/30/2025
• Manav Gupta from UBS set a target price of $27.0 on 08/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of NETGEAR lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocacy related to networking technology, cybersecurity requirements, data-protection standards, and manufacturing. Advocacy related to networking technology, cybersecurity requirements, data-protection standards, and manufacturing."

You can find more data on corporate lobbying on Quiver Quantitative.

NTGR Insider Trading Activity

NTGR insiders have traded $NTGR stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $NTGR stock by insiders over the last 6 months:

• BRADLEY MAIORINO sold 13,063 shares for an estimated $460,601
• SHRAVAN GOLI has made 0 purchases and 3 sales selling 13,804 shares for an estimated $368,230.
• PRAMOD BADJATE (President & GM, NFB) sold 4,000 shares for an estimated $98,400
• GRAEME MCLINDIN (VP, Mobile) has made 0 purchases and 2 sales selling 1,622 shares for an estimated $50,715.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NTGR Hedge Fund Activity

We have seen 99 institutional investors add shares of NTGR stock to their portfolio, and 97 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• LAZARD ASSET MANAGEMENT LLC added 256,266 shares (+87.6%) to their portfolio in Q3 2025, for an estimated $8,300,455
• INVESCO LTD. removed 248,231 shares (-70.7%) from their portfolio in Q3 2025, for an estimated $8,040,202
• JACOBS LEVY EQUITY MANAGEMENT, INC added 218,347 shares (+43.7%) to their portfolio in Q3 2025, for an estimated $7,072,259
• CINCTIVE CAPITAL MANAGEMENT LP added 198,597 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,432,556
• CITADEL ADVISORS LLC removed 196,742 shares (-84.1%) from their portfolio in Q3 2025, for an estimated $6,372,473
• MILLENNIUM MANAGEMENT LLC removed 173,148 shares (-78.1%) from their portfolio in Q3 2025, for an estimated $5,608,263
• PORTOLAN CAPITAL MANAGEMENT, LLC removed 169,294 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,483,432

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NTGR Analyst Ratings

Wall Street analysts have issued reports on $NTGR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Raymond James issued a "Outperform" rating on 10/30/2025
• Seaport Global issued a "Buy" rating on 10/01/2025

To track analyst ratings and price targets for NTGR, check out Quiver Quantitative's $NTGR forecast page.

NTGR Price Targets

Multiple analysts have issued price targets for $NTGR recently. We have seen 3 analysts offer price targets for $NTGR in the last 6 months, with a median target of $40.0.

Here are some recent targets:

• Adam Tindle from Raymond James set a target price of $37.0 on 10/30/2025
• Tore Svanberg from Stifel set a target price of $40.0 on 10/17/2025
• Jay Goldberg from Seaport Global set a target price of $40.0 on 10/01/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of UNIVERSAL TECHNICAL INSTITUTE lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocate on issues related to higher education"

You can find more data on corporate lobbying on Quiver Quantitative.

UTI Insider Trading Activity

UTI insiders have traded $UTI stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $UTI stock by insiders over the last 6 months:

• CAPITAL MANAGEMENT, LLC COLISEUM has made 6 purchases buying 1,255,173 shares for an estimated $30,813,450 and 0 sales.
• ROBERT THOMAS DEVINCENZI has made 2 purchases buying 10,000 shares for an estimated $253,990 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UTI Hedge Fund Activity

We have seen 124 institutional investors add shares of UTI stock to their portfolio, and 141 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 1,052,250 shares (-77.3%) from their portfolio in Q3 2025, for an estimated $34,250,737
• LORD, ABBETT & CO. LLC removed 948,967 shares (-46.7%) from their portfolio in Q3 2025, for an estimated $30,888,875
• PRICE T ROWE ASSOCIATES INC /MD/ added 931,489 shares (+2519.2%) to their portfolio in Q3 2025, for an estimated $30,319,966
• PERRITT CAPITAL MANAGEMENT INC removed 902,386 shares (-97.2%) from their portfolio in Q3 2025, for an estimated $29,372,664
• THRIVENT FINANCIAL FOR LUTHERANS added 857,889 shares (+inf%) to their portfolio in Q3 2025, for an estimated $27,924,286
• ROCKEFELLER CAPITAL MANAGEMENT L.P. added 736,168 shares (+inf%) to their portfolio in Q3 2025, for an estimated $23,962,268
• BLACKROCK, INC. added 719,979 shares (+22.0%) to their portfolio in Q3 2025, for an estimated $23,435,316

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UTI Analyst Ratings

Wall Street analysts have issued reports on $UTI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barrington Research issued a "Outperform" rating on 01/21/2026
• Rosenblatt issued a "Buy" rating on 11/20/2025

To track analyst ratings and price targets for UTI, check out Quiver Quantitative's $UTI forecast page.

UTI Price Targets

Multiple analysts have issued price targets for $UTI recently. We have seen 2 analysts offer price targets for $UTI in the last 6 months, with a median target of $36.0.

Here are some recent targets:

• Alexander Paris from Barrington Research set a target price of $36.0 on 01/21/2026
• Steve Frankel from Rosenblatt set a target price of $36.0 on 11/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocating for medicines to protect pigs from harmful diseases and lower the mortality rate of newborn pigs"

You can find more data on corporate lobbying on Quiver Quantitative.

PAHC Insider Trading Activity

PAHC insiders have traded $PAHC stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.

Here’s a breakdown of recent trading of $PAHC stock by insiders over the last 6 months:

• JACK BENDHEIM (President and CEO) has made 0 purchases and 50 sales selling 267,800 shares for an estimated $11,327,351.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PAHC Hedge Fund Activity

We have seen 120 institutional investors add shares of PAHC stock to their portfolio, and 97 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• EXODUSPOINT CAPITAL MANAGEMENT, LP removed 663,611 shares (-97.5%) from their portfolio in Q3 2025, for an estimated $26,849,701
• FMR LLC added 537,958 shares (+902.7%) to their portfolio in Q3 2025, for an estimated $21,765,780
• BRANDES INVESTMENT PARTNERS, LP removed 336,900 shares (-89.8%) from their portfolio in Q3 2025, for an estimated $13,630,974
• MILLENNIUM MANAGEMENT LLC removed 271,310 shares (-94.8%) from their portfolio in Q3 2025, for an estimated $10,977,202
• AMERICAN CENTURY COMPANIES INC removed 227,855 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,219,013
• JPMORGAN CHASE & CO added 225,110 shares (+1730.9%) to their portfolio in Q3 2025, for an estimated $9,107,950
• LORD, ABBETT & CO. LLC added 136,264 shares (+inf%) to their portfolio in Q3 2025, for an estimated $5,513,241

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PAHC Analyst Ratings

Wall Street analysts have issued reports on $PAHC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 11/07/2025
• B of A Securities issued a "Underperform" rating on 08/29/2025

To track analyst ratings and price targets for PAHC, check out Quiver Quantitative's $PAHC forecast page.

PAHC Price Targets

Multiple analysts have issued price targets for $PAHC recently. We have seen 2 analysts offer price targets for $PAHC in the last 6 months, with a median target of $38.5.

Here are some recent targets:

• Ekaterina Knyazkova from JP Morgan set a target price of $50.0 on 11/07/2025
• Derik De Bruin from B of A Securities set a target price of $27.0 on 08/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$40,000 of 3D SYSTEMS CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Support Additive Manufacturing for defense and aerospace systems in the FY26 Continuing Resolution and FY 26 Defense Appropriations Act"

You can find more data on corporate lobbying on Quiver Quantitative.

DDD Hedge Fund Activity

We have seen 89 institutional investors add shares of DDD stock to their portfolio, and 78 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS added 5,208,333 shares (+inf%) to their portfolio in Q3 2025, for an estimated $15,104,165
• MILLENNIUM MANAGEMENT LLC removed 3,088,172 shares (-97.9%) from their portfolio in Q3 2025, for an estimated $8,955,698
• D. E. SHAW & CO., INC. added 2,483,561 shares (+353.2%) to their portfolio in Q3 2025, for an estimated $7,202,326
• CITADEL ADVISORS LLC added 2,246,265 shares (+834.2%) to their portfolio in Q3 2025, for an estimated $6,514,168
• GOLDMAN SACHS GROUP INC added 1,722,749 shares (+517.5%) to their portfolio in Q3 2025, for an estimated $4,995,972
• UBS GROUP AG removed 1,435,942 shares (-55.4%) from their portfolio in Q3 2025, for an estimated $4,164,231
• TWO SIGMA ADVISERS, LP added 1,258,800 shares (+114.3%) to their portfolio in Q3 2025, for an estimated $3,650,520

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,810,000 of PFIZER INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act S 832 - EPIC Act of 2025 S 864 - HELP Copays ACT S 882 - Patients Before Middlemen Act Prescription Drug-Use-Related Software (PDURS): Digital Medicine Lyme Disease Issues Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients IRA Biosimilars Pause Fix, Biosimilar Legislation H.R. 5256 - 340B Access ACT Inflation Reduction Act (IRA): Orphan Drug Exemption, Pill Penalty, Biosimilar Pause Vaccine Coverage and Access Drug Pricing Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform S 1702 - Access to Prescription Digital Therapeutics Act of 2025 Digital Therapeutics International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United States-Mexico-Canada Agreement (USMCA)"

You can find more data on corporate lobbying on Quiver Quantitative.

PFE Congressional Stock Trading

Members of Congress have traded $PFE stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/18 and 2 sales worth up to $30,000 on 12/19, 08/05.
• REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PFE Hedge Fund Activity

We have seen 1,276 institutional investors add shares of PFE stock to their portfolio, and 1,389 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 24,513,278 shares (+55.9%) to their portfolio in Q3 2025, for an estimated $624,598,323
• WELLINGTON MANAGEMENT GROUP LLP removed 16,541,586 shares (-21.5%) from their portfolio in Q3 2025, for an estimated $421,479,611
• MILLENNIUM MANAGEMENT LLC removed 12,237,392 shares (-87.4%) from their portfolio in Q3 2025, for an estimated $311,808,748
• BNP PARIBAS FINANCIAL MARKETS removed 11,413,258 shares (-54.2%) from their portfolio in Q3 2025, for an estimated $290,809,813
• ROYAL BANK OF CANADA added 9,722,744 shares (+33.0%) to their portfolio in Q3 2025, for an estimated $247,735,517
• THORNBURG INVESTMENT MANAGEMENT INC removed 9,009,301 shares (-86.1%) from their portfolio in Q3 2025, for an estimated $229,556,989
• STARBOARD VALUE LP removed 8,542,149 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $217,653,956

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PFE Analyst Ratings

Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 11/24/2025

To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.

PFE Price Targets

Multiple analysts have issued price targets for $PFE recently. We have seen 7 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.

Here are some recent targets:

• Michael Yee from UBS set a target price of $25.0 on 01/07/2026
• Terence Flynn from Morgan Stanley set a target price of $27.0 on 12/17/2025
• Jason Gerberry from B of A Securities set a target price of $28.0 on 12/15/2025
• Geoff Meacham from Citigroup set a target price of $26.0 on 12/02/2025
• Vamil Divan from Guggenheim set a target price of $35.0 on 11/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$15,000 of MORNINGSTAR DBRS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to competition in the credit rating industry."

You can find more data on corporate lobbying on Quiver Quantitative.

MORN Congressional Stock Trading

Members of Congress have traded $MORN stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MORN stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.
• REPRESENTATIVE APRIL MCCLAIN DELANEY purchased up to $50,000 on 08/02.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MORN Insider Trading Activity

MORN insiders have traded $MORN stock on the open market 107 times in the past 6 months. Of those trades, 0 have been purchases and 107 have been sales.

Here’s a breakdown of recent trading of $MORN stock by insiders over the last 6 months:

• JOSEPH D MANSUETO (Executive Chairman) has made 0 purchases and 106 sales selling 200,000 shares for an estimated $47,340,031.
• CAROLINE J TSAY sold 600 shares for an estimated $131,090

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MORN Hedge Fund Activity

We have seen 239 institutional investors add shares of MORN stock to their portfolio, and 246 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SELECT EQUITY GROUP, L.P. added 990,401 shares (+89.0%) to their portfolio in Q3 2025, for an estimated $229,782,936
• BANK OF AMERICA CORP /DE/ removed 752,469 shares (-82.5%) from their portfolio in Q3 2025, for an estimated $174,580,332
• MILLENNIUM MANAGEMENT LLC removed 512,417 shares (-63.2%) from their portfolio in Q3 2025, for an estimated $118,885,868
• AQR CAPITAL MANAGEMENT LLC added 314,275 shares (+106.9%) to their portfolio in Q3 2025, for an estimated $72,914,942
• GOLDMAN SACHS GROUP INC removed 279,027 shares (-73.9%) from their portfolio in Q3 2025, for an estimated $64,737,054
• WASATCH ADVISORS LP removed 272,916 shares (-42.3%) from their portfolio in Q3 2025, for an estimated $63,319,241
• RENAISSANCE TECHNOLOGIES LLC added 195,600 shares (+73.8%) to their portfolio in Q3 2025, for an estimated $45,381,156

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MORN Analyst Ratings

Wall Street analysts have issued reports on $MORN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 10/30/2025

To track analyst ratings and price targets for MORN, check out Quiver Quantitative's $MORN forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$330,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act"

You can find more data on corporate lobbying on Quiver Quantitative.

HIMS Congressional Stock Trading

Members of Congress have traded $HIMS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $HIMS stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HIMS Insider Trading Activity

HIMS insiders have traded $HIMS stock on the open market 53 times in the past 6 months. Of those trades, 0 have been purchases and 53 have been sales.

Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:

• ANDREW DUDUM (Chief Executive Officer) has made 0 purchases and 17 sales selling 1,076,432 shares for an estimated $53,976,385.
• OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 12 sales selling 364,347 shares for an estimated $19,158,373.
• PATRICK HARRISON CARROLL (Chief Medical Officer) has made 0 purchases and 3 sales selling 80,042 shares for an estimated $4,088,809.
• MICHAEL CHI (Chief Operating Officer) has made 0 purchases and 8 sales selling 61,499 shares for an estimated $3,398,164.
• SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 9 sales selling 23,531 shares for an estimated $1,166,808.
• IRENE BECKLUND (PAO) has made 0 purchases and 2 sales selling 16,821 shares for an estimated $733,472.
• DEBORAH M. AUTOR (Chief Policy Officer) sold 7,054 shares for an estimated $258,952
• GARCIA ANDREA G PEREZ sold 2,500 shares for an estimated $97,925

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HIMS Hedge Fund Activity

We have seen 294 institutional investors add shares of HIMS stock to their portfolio, and 255 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 15,045,710 shares (+549.0%) to their portfolio in Q3 2025, for an estimated $853,392,671
• SRS INVESTMENT MANAGEMENT, LLC removed 4,000,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $226,880,000
• TIDAL INVESTMENTS LLC added 2,707,111 shares (+1779.6%) to their portfolio in Q3 2025, for an estimated $153,547,335
• FARALLON CAPITAL MANAGEMENT LLC added 2,533,271 shares (+30.8%) to their portfolio in Q3 2025, for an estimated $143,687,131
• PRICE T ROWE ASSOCIATES INC /MD/ added 2,504,252 shares (+444.1%) to their portfolio in Q3 2025, for an estimated $142,041,173
• RENAISSANCE TECHNOLOGIES LLC added 2,227,400 shares (+32.4%) to their portfolio in Q3 2025, for an estimated $126,338,128
• D. E. SHAW & CO., INC. removed 1,886,971 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $107,028,995

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HIMS Analyst Ratings

Wall Street analysts have issued reports on $HIMS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 11/04/2025
• B of A Securities issued a "Underperform" rating on 11/04/2025
• Canaccord Genuity issued a "Buy" rating on 09/12/2025

To track analyst ratings and price targets for HIMS, check out Quiver Quantitative's $HIMS forecast page.

HIMS Price Targets

Multiple analysts have issued price targets for $HIMS recently. We have seen 6 analysts offer price targets for $HIMS in the last 6 months, with a median target of $42.5.

Here are some recent targets:

• Mark Mahaney from Evercore ISI Group set a target price of $33.0 on 01/12/2026
• Glen Santangelo from Barclays set a target price of $48.0 on 12/09/2025
• David Larsen from BTIG set a target price of $85.0 on 11/04/2025
• Allen Lutz from B of A Securities set a target price of $32.0 on 11/04/2025
• Maria Ripps from Canaccord Genuity set a target price of $68.0 on 09/12/2025
• Jailendra Singh from Truist Securities set a target price of $37.0 on 08/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$80,000 of VERTEX ENERGY OPERATING LLC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocate on issues related to energy and energy services. Advocate on issues related to energy and energy services."

You can find more data on corporate lobbying on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of INTUIT INC. AND AFFILIATES (FORMERLY INTUIT INC.) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Promote small business development and growth Support small business regulatory modernization Expanding access to capital Promote financial health and literacy for small businesses and consumers. Support greater access to financial services and financial inclusion. Promote payments infrastructure modernization and market competition, HR 915."

You can find more data on corporate lobbying on Quiver Quantitative.

INTU Congressional Stock Trading

Members of Congress have traded $INTU stock 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $INTU stock by members of Congress over the last 6 months:

• SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 2 purchases worth up to $100,000 on 12/29, 09/24 and 0 sales.
• REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 10/01.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/13 and 1 sale worth up to $15,000 on 09/11.
• SENATOR JOHN W. HICKENLOOPER purchased up to $250,000 on 09/02.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

INTU Insider Trading Activity

INTU insiders have traded $INTU stock on the open market 118 times in the past 6 months. Of those trades, 0 have been purchases and 118 have been sales.

Here’s a breakdown of recent trading of $INTU stock by insiders over the last 6 months:

• SCOTT D COOK has made 0 purchases and 100 sales selling 494,894 shares for an estimated $327,893,677.
• SASAN K GOODARZI (CEO, President and Director) has made 0 purchases and 2 sales selling 41,000 shares for an estimated $26,653,960.
• SANDEEP AUJLA (EVP and CFO) has made 0 purchases and 5 sales selling 3,644 shares for an estimated $2,401,358.
• RICHARD L DALZELL has made 0 purchases and 11 sales selling 1,998 shares for an estimated $1,321,068.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

INTU Hedge Fund Activity

We have seen 1,118 institutional investors add shares of INTU stock to their portfolio, and 942 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,338,608 shares (+100.1%) to their portfolio in Q3 2025, for an estimated $2,279,968,789
• PRICE T ROWE ASSOCIATES INC /MD/ removed 1,916,133 shares (-23.3%) from their portfolio in Q3 2025, for an estimated $1,308,546,387
• WELLINGTON MANAGEMENT GROUP LLP removed 1,828,083 shares (-31.2%) from their portfolio in Q3 2025, for an estimated $1,248,416,161
• JPMORGAN CHASE & CO added 1,748,269 shares (+19.8%) to their portfolio in Q3 2025, for an estimated $1,193,910,382
• BLACKROCK, INC. added 1,672,758 shares (+6.5%) to their portfolio in Q3 2025, for an estimated $1,142,343,165
• ALLIANCEBERNSTEIN L.P. added 1,295,199 shares (+183.8%) to their portfolio in Q3 2025, for an estimated $884,504,349
• PARNASSUS INVESTMENTS, LLC removed 1,134,238 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $774,582,472

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

INTU Analyst Ratings

Wall Street analysts have issued reports on $INTU in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Cowen issued a "Buy" rating on 01/08/2026
• BMO Capital issued a "Outperform" rating on 11/21/2025
• Wells Fargo issued a "Overweight" rating on 11/21/2025
• RBC Capital issued a "Outperform" rating on 11/21/2025
• Evercore ISI Group issued a "Outperform" rating on 11/18/2025
• Keybanc issued a "Overweight" rating on 08/22/2025
• Citigroup issued a "Buy" rating on 08/22/2025

To track analyst ratings and price targets for INTU, check out Quiver Quantitative's $INTU forecast page.

INTU Price Targets

Multiple analysts have issued price targets for $INTU recently. We have seen 15 analysts offer price targets for $INTU in the last 6 months, with a median target of $802.0.

Here are some recent targets:

• Jared Levine from TD Cowen set a target price of $802.0 on 01/08/2026
• Michael Turrin from Wells Fargo set a target price of $700.0 on 01/08/2026
• Arvind Ramnani from Truist Securities set a target price of $739.0 on 01/06/2026
• Rishi Jaluria from RBC Capital set a target price of $850.0 on 11/21/2025
• Daniel Jester from BMO Capital set a target price of $810.0 on 11/21/2025
• Kirk Materne from Evercore ISI Group set a target price of $875.0 on 11/18/2025
• Steven Enders from Citigroup set a target price of $803.0 on 08/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of ACADIA HEALTHCARE COMPANY INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to healthcare, behavioral health, and regulatory framework."

You can find more data on corporate lobbying on Quiver Quantitative.

ACHC Hedge Fund Activity

We have seen 137 institutional investors add shares of ACHC stock to their portfolio, and 166 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ENGINE CAPITAL MANAGEMENT, LP added 2,585,574 shares (+inf%) to their portfolio in Q3 2025, for an estimated $64,018,812
• KHROM CAPITAL MANAGEMENT LLC added 2,556,469 shares (+103.0%) to their portfolio in Q3 2025, for an estimated $63,298,172
• BLACKROCK, INC. added 1,864,967 shares (+20.4%) to their portfolio in Q3 2025, for an estimated $46,176,582
• GW&K INVESTMENT MANAGEMENT, LLC removed 1,349,272 shares (-85.4%) from their portfolio in Q3 2025, for an estimated $33,407,974
• DEERFIELD MANAGEMENT COMPANY, L.P. added 1,189,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $29,439,640
• RUBRIC CAPITAL MANAGEMENT LP added 1,100,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $27,236,000
• WELLINGTON MANAGEMENT GROUP LLP added 993,205 shares (+11.8%) to their portfolio in Q3 2025, for an estimated $24,591,755

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ACHC Analyst Ratings

Wall Street analysts have issued reports on $ACHC in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Keybanc issued a "Overweight" rating on 11/18/2025
• RBC Capital issued a "Outperform" rating on 11/12/2025
• Guggenheim issued a "Buy" rating on 11/10/2025
• UBS issued a "Buy" rating on 11/07/2025
• Raymond James issued a "Outperform" rating on 10/03/2025

To track analyst ratings and price targets for ACHC, check out Quiver Quantitative's $ACHC forecast page.

ACHC Price Targets

Multiple analysts have issued price targets for $ACHC recently. We have seen 14 analysts offer price targets for $ACHC in the last 6 months, with a median target of $18.5.

Here are some recent targets:

• Brian Tanquilut from Jefferies set a target price of $15.0 on 01/22/2026
• Ryan Langston from TD Cowen set a target price of $22.0 on 01/16/2026
• Ben Hendrix from RBC Capital set a target price of $17.0 on 01/14/2026
• Ann Hynes from Mizuho set a target price of $17.0 on 12/18/2025
• Andrew Mok from Barclays set a target price of $14.0 on 12/04/2025
• Whit Mayo from Leerink Partners set a target price of $14.0 on 12/03/2025
• Matthew Gillmor from Keybanc set a target price of $25.0 on 12/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$420,000 of EXACT SCIENCES lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. Support colorectal cancer screening standards Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 7714 Colorectal Cancer Early Detection Act Support S 1717 Ensuring Patient Access to Critical Breakthrough Products Act Support veteran access to guideline-recommended colorectal cancer screening."

You can find more data on corporate lobbying on Quiver Quantitative.

EXAS Insider Trading Activity

EXAS insiders have traded $EXAS stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $EXAS stock by insiders over the last 6 months:

• KATHERINE S ZANOTTI sold 12,000 shares for an estimated $780,000
• JACOB A ORVILLE (EVP, GM, Screening) sold 5,000 shares for an estimated $375,000
• JAMES HERRIOTT (SVP, General Counsel & Sec) has made 0 purchases and 3 sales selling 4,000 shares for an estimated $265,120.
• BRIAN BARANICK (EVP, GM, Precision Oncology) sold 2,858 shares for an estimated $200,288
• JAMES EDWARD DOYLE has made 0 purchases and 2 sales selling 3,485 shares for an estimated $182,399.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EXAS Hedge Fund Activity

We have seen 291 institutional investors add shares of EXAS stock to their portfolio, and 257 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 8,241,935 shares (-30.6%) from their portfolio in Q3 2025, for an estimated $450,916,263
• WELLINGTON MANAGEMENT GROUP LLP removed 6,677,809 shares (-55.6%) from their portfolio in Q3 2025, for an estimated $365,342,930
• CITADEL ADVISORS LLC added 3,506,084 shares (+805.1%) to their portfolio in Q3 2025, for an estimated $191,817,855
• CANADA PENSION PLAN INVESTMENT BOARD added 2,500,056 shares (+2439.1%) to their portfolio in Q3 2025, for an estimated $136,778,063
• AMERIPRISE FINANCIAL INC added 2,270,039 shares (+102.1%) to their portfolio in Q3 2025, for an estimated $124,193,833
• ARK INVESTMENT MANAGEMENT LLC added 2,186,132 shares (+6072588.9%) to their portfolio in Q3 2025, for an estimated $119,603,281
• CAPITAL WORLD INVESTORS removed 2,059,161 shares (-11.3%) from their portfolio in Q3 2025, for an estimated $112,656,698

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

EXAS Analyst Ratings

Wall Street analysts have issued reports on $EXAS in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Piper Sandler issued a "Overweight" rating on 11/11/2025
• TD Cowen issued a "Buy" rating on 11/04/2025
• Baird issued a "Outperform" rating on 11/04/2025
• Evercore ISI Group issued a "Outperform" rating on 10/07/2025
• Craig-Hallum issued a "Buy" rating on 09/11/2025

To track analyst ratings and price targets for EXAS, check out Quiver Quantitative's $EXAS forecast page.

EXAS Price Targets

Multiple analysts have issued price targets for $EXAS recently. We have seen 16 analysts offer price targets for $EXAS in the last 6 months, with a median target of $86.5.

Here are some recent targets:

• Anthony Petrone from Mizuho set a target price of $105.0 on 01/20/2026
• Vijay Kumar from Evercore ISI Group set a target price of $105.0 on 01/05/2026
• Kyle Mikson from Canaccord Genuity set a target price of $105.0 on 11/25/2025
• Brandon Couillard from Jefferies set a target price of $105.0 on 11/24/2025
• Brandon Couillard from Wells Fargo set a target price of $105.0 on 11/21/2025
• Luke Sergott from Barclays set a target price of $105.0 on 11/21/2025
• David Westenberg from Piper Sandler set a target price of $80.0 on 11/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$25,000 of TC ENERGY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Energy and infrastructure"

You can find more data on corporate lobbying on Quiver Quantitative.

TRP Hedge Fund Activity

We have seen 262 institutional investors add shares of TRP stock to their portfolio, and 269 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GOLDMAN SACHS GROUP INC added 39,624,187 shares (+155.9%) to their portfolio in Q3 2025, for an estimated $2,155,952,014
• CLEARBRIDGE INVESTMENTS, LLC added 7,240,870 shares (+648.8%) to their portfolio in Q3 2025, for an estimated $393,975,736
• BANK OF MONTREAL /CAN/ removed 6,286,123 shares (-13.8%) from their portfolio in Q3 2025, for an estimated $342,027,952
• BANK OF NOVA SCOTIA removed 5,460,982 shares (-32.4%) from their portfolio in Q3 2025, for an estimated $297,132,030
• AMERICAN CENTURY COMPANIES INC added 5,435,310 shares (+514.5%) to their portfolio in Q3 2025, for an estimated $295,735,217
• MURCHINSON LTD. added 4,050,068 shares (+inf%) to their portfolio in Q3 2025, for an estimated $220,364,199
• MONDRIAN INVESTMENT PARTNERS LTD removed 3,505,260 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $190,721,196

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TRP Analyst Ratings

Wall Street analysts have issued reports on $TRP in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• RBC Capital issued a "Outperform" rating on 11/07/2025
• CIBC issued a "Outperformer" rating on 11/07/2025
• Scotiabank issued a "Sector Outperform" rating on 11/07/2025
• Barclays issued a "Overweight" rating on 10/14/2025

To track analyst ratings and price targets for TRP, check out Quiver Quantitative's $TRP forecast page.

TRP Price Targets

Multiple analysts have issued price targets for $TRP recently. We have seen 6 analysts offer price targets for $TRP in the last 6 months, with a median target of $81.0.

Here are some recent targets:

• Spiro Dounis from Citigroup set a target price of $82.0 on 11/20/2025
• Robert Catellier from CIBC set a target price of $78.0 on 11/07/2025
• Robert Hope from Scotiabank set a target price of $81.0 on 11/07/2025
• Maurice Choy from RBC Capital set a target price of $84.0 on 11/07/2025
• Aaron Macneil from TD Securities set a target price of $81.0 on 10/17/2025
• Theresa Chen from Barclays set a target price of $80.0 on 10/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$280,000 of MADRIGAL PHARMACEUTICALS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to CMMI drug pricing Most Favored Nation drug pricing; Issues related to CMMI drug pricing"

You can find more data on corporate lobbying on Quiver Quantitative.

MDGL Insider Trading Activity

MDGL insiders have traded $MDGL stock on the open market 244 times in the past 6 months. Of those trades, 54 have been purchases and 190 have been sales.

Here’s a breakdown of recent trading of $MDGL stock by insiders over the last 6 months:

• PAUL A FRIEDMAN has made 0 purchases and 67 sales selling 225,580 shares for an estimated $91,113,997.
• BROS. ADVISORS LP BAKER has made 54 purchases buying 165,683 shares for an estimated $61,921,024 and 0 sales.
• REBECCA TAUB has made 0 purchases and 52 sales selling 86,001 shares for an estimated $37,654,339.
• KENNETH BATE has made 0 purchases and 17 sales selling 26,575 shares for an estimated $11,679,362.
• WILLIAM JOHN SIBOLD (President and CEO) has made 0 purchases and 4 sales selling 17,295 shares for an estimated $7,672,313.
• RICHARD S LEVY has made 0 purchases and 14 sales selling 8,500 shares for an estimated $4,428,197.
• MARDI DIER (EVP and CFO) has made 0 purchases and 15 sales selling 4,173 shares for an estimated $2,413,416.
• CAROLE HUNTSMAN (Chief Commercial Officer) has made 0 purchases and 11 sales selling 1,958 shares for an estimated $1,082,986.
• SHANNON T KELLEY (General Counsel) has made 0 purchases and 10 sales selling 1,996 shares for an estimated $823,799.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MDGL Hedge Fund Activity

We have seen 189 institutional investors add shares of MDGL stock to their portfolio, and 150 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP added 397,076 shares (+5381.2%) to their portfolio in Q3 2025, for an estimated $182,122,878
• JANUS HENDERSON GROUP PLC removed 349,063 shares (-15.9%) from their portfolio in Q3 2025, for an estimated $160,101,235
• UBS GROUP AG removed 288,371 shares (-57.0%) from their portfolio in Q3 2025, for an estimated $132,264,242
• ADAGE CAPITAL PARTNERS GP, L.L.C. removed 287,663 shares (-76.5%) from their portfolio in Q3 2025, for an estimated $131,939,511
• GOLDMAN SACHS GROUP INC added 196,260 shares (+103.4%) to their portfolio in Q3 2025, for an estimated $90,016,611
• PAULSON & CO. INC. removed 182,000 shares (-8.7%) from their portfolio in Q3 2025, for an estimated $83,476,120
• BAKER BROS. ADVISORS LP added 165,683 shares (+8.4%) to their portfolio in Q3 2025, for an estimated $75,992,164

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MDGL Analyst Ratings

Wall Street analysts have issued reports on $MDGL in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citizens issued a "Market Outperform" rating on 01/20/2026
• HC Wainwright & Co. issued a "Buy" rating on 11/21/2025
• Oppenheimer issued a "Outperform" rating on 11/20/2025
• Truist Securities issued a "Buy" rating on 11/19/2025
• Canaccord Genuity issued a "Buy" rating on 11/13/2025
• Cantor Fitzgerald issued a "Overweight" rating on 11/05/2025
• Piper Sandler issued a "Overweight" rating on 10/15/2025

To track analyst ratings and price targets for MDGL, check out Quiver Quantitative's $MDGL forecast page.

MDGL Price Targets

Multiple analysts have issued price targets for $MDGL recently. We have seen 12 analysts offer price targets for $MDGL in the last 6 months, with a median target of $603.5.

Here are some recent targets:

• Jonathan Wolleben from Citizens set a target price of $745.0 on 01/20/2026
• Yasmeen Rahimi from Piper Sandler set a target price of $900.0 on 12/19/2025
• William Woods from B. Riley Securities set a target price of $670.0 on 12/11/2025
• Andrew S. Fein from HC Wainwright & Co. set a target price of $620.0 on 11/21/2025
• Jay Olson from Oppenheimer set a target price of $650.0 on 11/20/2025
• Srikripa Devarakonda from Truist Securities set a target price of $640.0 on 11/19/2025
• Edward Nash from Canaccord Genuity set a target price of $587.0 on 11/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of DENTSPLY SIRONA INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Competitive bidding for urological products, trace and tariffs"

You can find more data on corporate lobbying on Quiver Quantitative.

XRAY Insider Trading Activity

XRAY insiders have traded $XRAY stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $XRAY stock by insiders over the last 6 months:

• GREGORY T LUCIER sold 82,200 shares for an estimated $915,708
• LESLIE F VARON purchased 9,337 shares for an estimated $99,999

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

XRAY Hedge Fund Activity

We have seen 223 institutional investors add shares of XRAY stock to their portfolio, and 182 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ removed 10,749,500 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $136,411,155
• ARMISTICE CAPITAL, LLC added 5,234,587 shares (+1044.0%) to their portfolio in Q3 2025, for an estimated $66,426,909
• JACOBS LEVY EQUITY MANAGEMENT, INC added 4,003,606 shares (+662.0%) to their portfolio in Q3 2025, for an estimated $50,805,760
• D. E. SHAW & CO., INC. added 1,669,643 shares (+136.1%) to their portfolio in Q3 2025, for an estimated $21,187,769
• BRICKWOOD ASSET MANAGEMENT LLP added 1,496,935 shares (+5515.8%) to their portfolio in Q3 2025, for an estimated $18,996,105
• INVENOMIC CAPITAL MANAGEMENT LP added 1,425,637 shares (+48.7%) to their portfolio in Q3 2025, for an estimated $18,091,333
• RUSSELL INVESTMENTS GROUP, LTD. added 1,153,271 shares (+1163.7%) to their portfolio in Q3 2025, for an estimated $14,635,008

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

XRAY Analyst Ratings

Wall Street analysts have issued reports on $XRAY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barrington Research issued a "Outperform" rating on 01/05/2026
• UBS issued a "Buy" rating on 08/08/2025

To track analyst ratings and price targets for XRAY, check out Quiver Quantitative's $XRAY forecast page.

XRAY Price Targets

Multiple analysts have issued price targets for $XRAY recently. We have seen 9 analysts offer price targets for $XRAY in the last 6 months, with a median target of $13.0.

Here are some recent targets:

• Steven Valiquette from Mizuho set a target price of $14.0 on 01/20/2026
• Michael Petusky from Barrington Research set a target price of $14.0 on 01/05/2026
• Jeffrey Johnson from Baird set a target price of $12.0 on 12/16/2025
• Glen Santangelo from Barclays set a target price of $12.0 on 12/09/2025
• Vik Chopra from Wells Fargo set a target price of $12.0 on 11/07/2025
• Lilia-Celine Lozada from JP Morgan set a target price of $12.0 on 11/07/2025
• Kevin Caliendo from UBS set a target price of $23.0 on 10/28/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$140,000 of HOWMET AEROSPACE INC FORMALLY KNOWN AS ARCONIC INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 4016 - FY26 Defense Appropriations (Metals Affordability Initiative, National Defense Stockpile); H.R. 3838 / S. 2296 - FY26 NDAA (Specialty Metals, Critical Minerals); H.R. 1 - One Big Beautiful Bill Act (National Defense Stockpile, Industrial Capacity); Forging & Casting Industrial Capacity Critical Materials, IEEPA Tariffs (Reciprocal, Brazil), Agreement on Trade in Civil Aircraft, Section 232 Tariffs (Aluminum, Steel, Critical Minerals, Automotive, Trucks, Aircraft / Engines), USMCA Agreement on Trade in Civil Aircraft, Section 232 (Aircraft / Engines) HR 4016 - FY26 Defense Appropriations (Metals Affordability Initiative, National Defense Stockpile); H.R. 1 - One Big Beautiful Bill Act (National Defense Stockpile, Industrial Capacity) H.R. 1 - One Big Beautiful Bill Act (International / Corporate Tax, Section 45x, R&D, Depreciation, National Defense Stockpile, Industrial Capacity), H.R. 4016 - FY26 Defense Appropriations (Metals Affordability Initiative, National Defense Stockpile), H.R. 3838 / S. 2296 - FY26 NDAA (Specialty Metals, Critical Minerals) H.R. 1 - One Big Beautiful Bill Act (International / Corporate Tax, Section 45x, R&D, Depreciation) Economic Development Heavy Duty NOx Rule (emissions standards), Endangerment Finding and GHG Vehicle Standards (emissions standards, proposed rulemaking)"

You can find more data on corporate lobbying on Quiver Quantitative.

HWM Congressional Stock Trading

Members of Congress have traded $HWM stock 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $HWM stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 1 purchase worth up to $15,000 on 10/30 and 3 sales worth up to $45,000 on 10/31, 10/30, 08/04.
• REPRESENTATIVE BYRON DONALDS has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 10/23, 08/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HWM Insider Trading Activity

HWM insiders have traded $HWM stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $HWM stock by insiders over the last 6 months:

• LOLA FELICE LIN (EVP, CL&CO and Secretary) sold 13,102 shares for an estimated $2,365,073

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HWM Hedge Fund Activity

We have seen 637 institutional investors add shares of HWM stock to their portfolio, and 541 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO removed 3,074,104 shares (-9.7%) from their portfolio in Q3 2025, for an estimated $603,231,427
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 2,447,458 shares (-17.4%) from their portfolio in Q3 2025, for an estimated $480,264,683
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,110,150 shares (+76.8%) to their portfolio in Q3 2025, for an estimated $414,074,734
• BLACKROCK, INC. added 2,092,504 shares (+4.5%) to their portfolio in Q3 2025, for an estimated $410,612,059
• JANUS HENDERSON GROUP PLC removed 1,184,362 shares (-12.4%) from their portfolio in Q3 2025, for an estimated $232,407,355
• BOSTON PARTNERS removed 1,023,868 shares (-34.1%) from their portfolio in Q3 2025, for an estimated $200,913,617
• INVESCO LTD. added 801,093 shares (+12.2%) to their portfolio in Q3 2025, for an estimated $157,198,479

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HWM Analyst Ratings

Wall Street analysts have issued reports on $HWM in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 01/13/2026
• B of A Securities issued a "Buy" rating on 11/14/2025
• JP Morgan issued a "Overweight" rating on 11/10/2025
• BTIG issued a "Buy" rating on 11/03/2025
• RBC Capital issued a "Outperform" rating on 10/31/2025
• TD Cowen issued a "Buy" rating on 10/31/2025
• Truist Securities issued a "Buy" rating on 10/15/2025

To track analyst ratings and price targets for HWM, check out Quiver Quantitative's $HWM forecast page.

HWM Price Targets

Multiple analysts have issued price targets for $HWM recently. We have seen 11 analysts offer price targets for $HWM in the last 6 months, with a median target of $227.0.

Here are some recent targets:

• John Godyn from Citigroup set a target price of $255.0 on 01/13/2026
• Ronald Epstein from B of A Securities set a target price of $250.0 on 11/14/2025
• Seth Seifman from JP Morgan set a target price of $227.0 on 11/10/2025
• Andre Madrid from BTIG set a target price of $240.0 on 11/03/2025
• Noah Poponak from Goldman Sachs set a target price of $226.0 on 11/03/2025
• Gavin Parsons from UBS set a target price of $209.0 on 10/31/2025
• Ken Herbert from RBC Capital set a target price of $235.0 on 10/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of ARCHER AVIATION INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Defense Authorization and Appropriations bills, FY-25 and FY-26. Issues related to Hybrid VTOL Aircraft technology development."

You can find more data on corporate lobbying on Quiver Quantitative.

ACHR Insider Trading Activity

ACHR insiders have traded $ACHR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $ACHR stock by insiders over the last 6 months:

• THOMAS PAUL MUNIZ (CHIEF TECHNOLOGY OFFICER) has made 0 purchases and 3 sales selling 301,781 shares for an estimated $2,526,032.
• ERIC LENTELL (Chief Legal & Strategy Officer) has made 0 purchases and 2 sales selling 90,426 shares for an estimated $791,975.
• TOSHA PERKINS (CHIEF PEOPLE PARTNERSHIPS OFF.) has made 0 purchases and 2 sales selling 87,793 shares for an estimated $757,857.
• PRIYA GUPTA (Interim CFO) has made 0 purchases and 2 sales selling 15,703 shares for an estimated $141,560.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ACHR Hedge Fund Activity

We have seen 296 institutional investors add shares of ACHR stock to their portfolio, and 184 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 16,452,398 shares (+45.8%) to their portfolio in Q3 2025, for an estimated $157,613,972
• D. E. SHAW & CO., INC. removed 15,948,972 shares (-94.6%) from their portfolio in Q3 2025, for an estimated $152,791,151
• STATE STREET CORP added 8,495,613 shares (+40.5%) to their portfolio in Q3 2025, for an estimated $81,387,972
• CITADEL ADVISORS LLC removed 6,963,031 shares (-80.2%) from their portfolio in Q3 2025, for an estimated $66,705,836
• JANE STREET GROUP, LLC removed 4,890,914 shares (-81.3%) from their portfolio in Q3 2025, for an estimated $46,854,956
• GOLDMAN SACHS GROUP INC removed 4,722,840 shares (-75.3%) from their portfolio in Q3 2025, for an estimated $45,244,807
• MORGAN STANLEY added 4,665,927 shares (+56.5%) to their portfolio in Q3 2025, for an estimated $44,699,580

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ACHR Analyst Ratings

Wall Street analysts have issued reports on $ACHR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Canaccord Genuity issued a "Buy" rating on 11/21/2025
• Needham issued a "Buy" rating on 11/07/2025
• HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for ACHR, check out Quiver Quantitative's $ACHR forecast page.

ACHR Price Targets

Multiple analysts have issued price targets for $ACHR recently. We have seen 5 analysts offer price targets for $ACHR in the last 6 months, with a median target of $11.0.

Here are some recent targets:

• Chris Pierce from Needham set a target price of $10.0 on 01/14/2026
• Anthony Valentini from Goldman Sachs set a target price of $11.0 on 12/01/2025
• Austin Moeller from Canaccord Genuity set a target price of $13.0 on 11/21/2025
• Bill Peterson from JP Morgan set a target price of $8.0 on 11/07/2025
• Amit Dayal from HC Wainwright & Co. set a target price of $18.0 on 08/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$75,000 of TWIST BIOSCIENCE CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Gene synthesis screening S.1071 - National Defense Authorization Act for Fiscal Year 2026 H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025 Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Robotics and Industrial Machinery (Docket No. 250924-0161 / XRIN 0694-XC138)"

You can find more data on corporate lobbying on Quiver Quantitative.

TWST Insider Trading Activity

TWST insiders have traded $TWST stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.

Here’s a breakdown of recent trading of $TWST stock by insiders over the last 6 months:

• EMILY M. LEPROUST (Chief Executive Officer) has made 0 purchases and 11 sales selling 86,883 shares for an estimated $2,700,762.
• PATRICK JOHN FINN (President and COO) has made 0 purchases and 10 sales selling 78,870 shares for an estimated $2,677,729.
• ADAM LAPONIS (Chief Financial Officer) has made 0 purchases and 8 sales selling 24,452 shares for an estimated $802,779.
• PAULA GREEN (SVP of Human Resources) has made 0 purchases and 11 sales selling 22,677 shares for an estimated $706,331.
• DENNIS CHO (See Remarks) has made 0 purchases and 12 sales selling 14,915 shares for an estimated $461,790.
• ROBERT F. WERNER (Chief Accounting Officer) has made 0 purchases and 10 sales selling 6,010 shares for an estimated $181,133.
• JAN JOHANNESSEN sold 7,044 shares for an estimated $174,479

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TWST Hedge Fund Activity

We have seen 135 institutional investors add shares of TWST stock to their portfolio, and 102 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• EDGEPOINT INVESTMENT GROUP INC. added 1,696,377 shares (+71.1%) to their portfolio in Q3 2025, for an estimated $47,736,048
• POINT72 ASSET MANAGEMENT, L.P. removed 1,628,357 shares (-75.4%) from their portfolio in Q3 2025, for an estimated $45,821,965
• SOLEUS CAPITAL MANAGEMENT, L.P. added 1,511,833 shares (+426.6%) to their portfolio in Q3 2025, for an estimated $42,542,980
• THRIVENT FINANCIAL FOR LUTHERANS added 1,456,368 shares (+21681.8%) to their portfolio in Q3 2025, for an estimated $40,982,195
• CITADEL ADVISORS LLC removed 1,388,301 shares (-92.3%) from their portfolio in Q3 2025, for an estimated $39,066,790
• ARTISAN PARTNERS LIMITED PARTNERSHIP added 1,349,867 shares (+26.7%) to their portfolio in Q3 2025, for an estimated $37,985,257
• MILLENNIUM MANAGEMENT LLC added 1,080,722 shares (+151.5%) to their portfolio in Q3 2025, for an estimated $30,411,517

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TWST Analyst Ratings

Wall Street analysts have issued reports on $TWST in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 11/17/2025
• Evercore ISI Group issued a "Outperform" rating on 10/07/2025

To track analyst ratings and price targets for TWST, check out Quiver Quantitative's $TWST forecast page.

TWST Price Targets

Multiple analysts have issued price targets for $TWST recently. We have seen 4 analysts offer price targets for $TWST in the last 6 months, with a median target of $41.5.

Here are some recent targets:

• Brendan Smith from TD Cowen set a target price of $43.0 on 01/08/2026
• Luke Sergott from Barclays set a target price of $39.0 on 12/15/2025
• Steven Etoch from Stephens & Co. set a target price of $41.0 on 11/04/2025
• Vijay Kumar from Evercore ISI Group set a target price of $42.0 on 10/07/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$80,000 of SIGA TECHNOLOGIES lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Biodefense funding"

You can find more data on corporate lobbying on Quiver Quantitative.

SIGA Hedge Fund Activity

We have seen 102 institutional investors add shares of SIGA stock to their portfolio, and 76 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 1,240,173 shares (-60.0%) from their portfolio in Q3 2025, for an estimated $11,347,582
• GENERAL AMERICAN INVESTORS CO INC removed 539,738 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $4,938,602
• AQR CAPITAL MANAGEMENT LLC added 328,725 shares (+1698.3%) to their portfolio in Q3 2025, for an estimated $3,007,833
• RENAISSANCE TECHNOLOGIES LLC removed 290,412 shares (-48.5%) from their portfolio in Q3 2025, for an estimated $2,657,269
• JANUS HENDERSON GROUP PLC added 269,507 shares (+1376.5%) to their portfolio in Q3 2025, for an estimated $2,465,989
• CITADEL ADVISORS LLC removed 269,332 shares (-19.3%) from their portfolio in Q3 2025, for an estimated $2,464,387
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 255,902 shares (+44.2%) to their portfolio in Q3 2025, for an estimated $2,341,503

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of GENMAB lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General Medicare/Medicaid Issues. 340B Issues. Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022."

You can find more data on corporate lobbying on Quiver Quantitative.

GMAB Hedge Fund Activity

We have seen 171 institutional investors add shares of GMAB stock to their portfolio, and 93 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PARADIGM BIOCAPITAL ADVISORS LP added 3,816,851 shares (+inf%) to their portfolio in Q3 2025, for an estimated $117,062,820
• CITADEL ADVISORS LLC removed 3,517,711 shares (-98.6%) from their portfolio in Q3 2025, for an estimated $107,888,196
• ORBIS ALLAN GRAY LTD added 3,157,606 shares (+39.9%) to their portfolio in Q3 2025, for an estimated $96,843,776
• MARSHALL WACE, LLP removed 1,374,075 shares (-72.0%) from their portfolio in Q3 2025, for an estimated $42,142,880
• MORGAN STANLEY removed 1,022,561 shares (-37.9%) from their portfolio in Q3 2025, for an estimated $31,361,945
• PERPETUAL LTD added 827,217 shares (+inf%) to their portfolio in Q4 2025, for an estimated $25,478,283
• VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 818,363 shares (-86.2%) from their portfolio in Q3 2025, for an estimated $25,099,193

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GMAB Analyst Ratings

Wall Street analysts have issued reports on $GMAB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 01/20/2026
• Truist Securities issued a "Buy" rating on 11/07/2025
• Guggenheim issued a "Buy" rating on 09/24/2025

To track analyst ratings and price targets for GMAB, check out Quiver Quantitative's $GMAB forecast page.

GMAB Price Targets

Multiple analysts have issued price targets for $GMAB recently. We have seen 4 analysts offer price targets for $GMAB in the last 6 months, with a median target of $43.0.

Here are some recent targets:

• Raghuram Selvaraju from HC Wainwright & Co. set a target price of $39.0 on 01/20/2026
• Asthika Goonewardene from Truist Securities set a target price of $48.0 on 11/07/2025
• Michael Schmitz from Guggenheim set a target price of $43.0 on 09/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$190,000 of TARGET CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Policy proposals related to ports and supply chain policies. Policy proposals related to organized retail crime. H.R. 2853/S. 1404, Combating Organized Retail Crime Act. Trade, tariff, and customs policies and proposals affecting retailers. Responsible sourcing policy proposals affecting retailers. Section 301 tariffs and IEEPA tariffs, including policies regarding de minimis shipments. Maintaining tax treatment of employer-sponsored health insurance. Tax treatment of telehealth. Issues related to corporate tax rate. Business state and local income and property tax deduction. Extension of Tax Cuts and Jobs Act (Pub. L. No. 115-97). H.R. 1, One Big Beautiful Bill Act, tax provisions. Extension of The Work Opportunity Tax Credit. Policy proposals related to labor. Policy proposals related to payments. Credit Card Competition Act."

You can find more data on corporate lobbying on Quiver Quantitative.

TGT Congressional Stock Trading

Members of Congress have traded $TGT stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $TGT stock by members of Congress over the last 6 months:

• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 08/18.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TGT Hedge Fund Activity

We have seen 663 institutional investors add shares of TGT stock to their portfolio, and 968 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 6,481,560 shares (+12.6%) to their portfolio in Q3 2025, for an estimated $581,395,932
• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 6,039,933 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $541,781,990
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 5,023,835 shares (-83.9%) from their portfolio in Q3 2025, for an estimated $450,637,999
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,967,755 shares (+62.7%) to their portfolio in Q3 2025, for an estimated $266,207,623
• DIAMOND HILL CAPITAL MANAGEMENT INC removed 2,268,921 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $203,522,213
• GOLDMAN SACHS GROUP INC removed 1,763,182 shares (-40.1%) from their portfolio in Q3 2025, for an estimated $158,157,425
• UBS GROUP AG removed 1,624,745 shares (-31.4%) from their portfolio in Q3 2025, for an estimated $145,739,626

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TGT Analyst Ratings

Wall Street analysts have issued reports on $TGT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• Argus Research issued a "Buy" rating on 12/01/2025
• DA Davidson issued a "Buy" rating on 11/20/2025
• Bernstein issued a "Underperform" rating on 11/20/2025
• RBC Capital issued a "Outperform" rating on 11/20/2025
• B of A Securities issued a "Underperform" rating on 11/20/2025
• Wolfe Research issued a "Underperform" rating on 09/18/2025
• UBS issued a "Buy" rating on 08/21/2025

To track analyst ratings and price targets for TGT, check out Quiver Quantitative's $TGT forecast page.

TGT Price Targets

Multiple analysts have issued price targets for $TGT recently. We have seen 20 analysts offer price targets for $TGT in the last 6 months, with a median target of $91.0.

Here are some recent targets:

• Spencer Hanus from Wolfe Research set a target price of $81.0 on 12/30/2025
• Greg Melich from Evercore ISI Group set a target price of $95.0 on 12/09/2025
• Christopher Graja from Argus Research set a target price of $125.0 on 12/01/2025
• Paul Lejuez from Citigroup set a target price of $89.0 on 11/20/2025
• Scot Ciccarelli from Truist Securities set a target price of $90.0 on 11/20/2025
• Peter Benedict from Baird set a target price of $92.0 on 11/20/2025
• Michael Baker from DA Davidson set a target price of $108.0 on 11/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$120,000 of DOCUSIGN INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to Government Modernization, Digital Transformation, and AI, including American AI Export Program RFI, US Tech Force Program, American by Design and Appropriations"

You can find more data on corporate lobbying on Quiver Quantitative.

DOCU Congressional Stock Trading

Members of Congress have traded $DOCU stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $DOCU stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

DOCU Insider Trading Activity

DOCU insiders have traded $DOCU stock on the open market 43 times in the past 6 months. Of those trades, 0 have been purchases and 43 have been sales.

Here’s a breakdown of recent trading of $DOCU stock by insiders over the last 6 months:

• ALLAN C. THYGESEN (President and CEO) has made 0 purchases and 7 sales selling 66,250 shares for an estimated $4,614,483.
• ROBERT CHATWANI (President General Mgr, Growth) has made 0 purchases and 8 sales selling 32,966 shares for an estimated $2,492,273.
• BLAKE JEFFREY GRAYSON (Chief Financial Officer) has made 0 purchases and 7 sales selling 32,024 shares for an estimated $2,358,247.
• JAMES P SHAUGHNESSY (Chief Legal Officer) has made 0 purchases and 6 sales selling 19,500 shares for an estimated $1,338,345.
• PETER SOLVIK sold 15,000 shares for an estimated $1,222,200
• PAULA HANSEN (Chief Revenue Officer) has made 0 purchases and 7 sales selling 12,000 shares for an estimated $830,256.
• ANNA MARRS has made 0 purchases and 3 sales selling 1,456 shares for an estimated $106,889.
• JAMES A BEER has made 0 purchases and 2 sales selling 900 shares for an estimated $67,419.
• TERESA BRIGGS has made 0 purchases and 2 sales selling 729 shares for an estimated $54,152.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DOCU Hedge Fund Activity

We have seen 401 institutional investors add shares of DOCU stock to their portfolio, and 384 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,804,009 shares (+83.0%) to their portfolio in Q3 2025, for an estimated $202,141,008
• FMR LLC removed 2,402,196 shares (-58.5%) from their portfolio in Q3 2025, for an estimated $173,174,309
• AMERICAN CENTURY COMPANIES INC removed 1,488,390 shares (-26.7%) from their portfolio in Q3 2025, for an estimated $107,298,035
• BALYASNY ASSET MANAGEMENT L.P. added 1,448,038 shares (+inf%) to their portfolio in Q3 2025, for an estimated $104,389,059
• ALYESKA INVESTMENT GROUP, L.P. removed 1,440,926 shares (-58.9%) from their portfolio in Q3 2025, for an estimated $103,876,355
• THRIVENT FINANCIAL FOR LUTHERANS added 1,318,741 shares (+3999.5%) to their portfolio in Q3 2025, for an estimated $95,068,038
• CAISSE DE DEPOT ET PLACEMENT DU QUEBEC removed 1,015,811 shares (-76.0%) from their portfolio in Q3 2025, for an estimated $73,229,814

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DOCU Analyst Ratings

Wall Street analysts have issued reports on $DOCU in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 12/17/2025
• JMP Securities issued a "Market Outperform" rating on 09/05/2025
• Citigroup issued a "Buy" rating on 09/05/2025

To track analyst ratings and price targets for DOCU, check out Quiver Quantitative's $DOCU forecast page.

DOCU Price Targets

Multiple analysts have issued price targets for $DOCU recently. We have seen 13 analysts offer price targets for $DOCU in the last 6 months, with a median target of $78.0.

Here are some recent targets:

• Rishi Jaluria from RBC Capital set a target price of $70.0 on 01/05/2026
• Allan Verkhovski from BTIG set a target price of $88.0 on 12/17/2025
• Brad Sills from B of A Securities set a target price of $82.0 on 12/05/2025
• Kirk Materne from Evercore ISI Group set a target price of $80.0 on 12/05/2025
• Karl Keirstead from UBS set a target price of $75.0 on 12/05/2025
• Rob Owens from Piper Sandler set a target price of $75.0 on 12/05/2025
• Michael Turrin from Wells Fargo set a target price of $75.0 on 12/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$90,000 of TRIPADVISOR LLC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to travel and technology. Issues around Section 230 of the Communications Decency Act of 1996. Issues related to online trust and safety. Issues related to Artificial Intelligence. The Hotel Fee Transparency Act, S.314/H.R. 1479. TICKET Act, S. 281. Issues related to Children's Online Safety. Issues around Section 230 of the Communications Decency Act of 1996. Issues related to treatment of metasearch sites and consumers in the travel industry. Issues related to competition in the travel and technology industries. Issues related to treatment of metasearch sites and consumers in the travel industry; issues related to online consumer reviews; The Hotel Fee Transparency Act, S.314/H.R. 1479."

You can find more data on corporate lobbying on Quiver Quantitative.

TRIP Insider Trading Activity

TRIP insiders have traded $TRIP stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $TRIP stock by insiders over the last 6 months:

• KRISTEN ANN DALTON (President, Brand Tripadvisor) sold 18,000 shares for an estimated $269,640
• SETH J KALVERT (Chief Legal Officer & Sec.) sold 10,880 shares for an estimated $218,004
• ALMIR AMBESKOVIC (CEO, TheFork) has made 0 purchases and 2 sales selling 4,115 shares for an estimated $65,105.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TRIP Hedge Fund Activity

We have seen 146 institutional investors add shares of TRIP stock to their portfolio, and 154 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BALYASNY ASSET MANAGEMENT L.P. removed 2,278,131 shares (-99.5%) from their portfolio in Q3 2025, for an estimated $37,042,410
• FIL LTD removed 1,919,584 shares (-42.8%) from their portfolio in Q3 2025, for an estimated $31,212,435
• CITADEL ADVISORS LLC removed 1,688,054 shares (-62.6%) from their portfolio in Q3 2025, for an estimated $27,447,758
• BANK OF AMERICA CORP /DE/ removed 1,683,664 shares (-85.6%) from their portfolio in Q3 2025, for an estimated $27,376,376
• ALYESKA INVESTMENT GROUP, L.P. added 1,651,184 shares (+inf%) to their portfolio in Q3 2025, for an estimated $26,848,251
• ROYAL BANK OF CANADA added 1,552,739 shares (+94.2%) to their portfolio in Q3 2025, for an estimated $25,247,536
• AMERIPRISE FINANCIAL INC added 1,445,607 shares (+24.2%) to their portfolio in Q3 2025, for an estimated $23,505,569

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TRIP Analyst Ratings

Wall Street analysts have issued reports on $TRIP in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Underweight" rating on 11/07/2025
• Mizuho issued a "Underperform" rating on 09/30/2025

To track analyst ratings and price targets for TRIP, check out Quiver Quantitative's $TRIP forecast page.

TRIP Price Targets

Multiple analysts have issued price targets for $TRIP recently. We have seen 7 analysts offer price targets for $TRIP in the last 6 months, with a median target of $17.0.

Here are some recent targets:

• Deepak Mathivanan from Cantor Fitzgerald set a target price of $14.0 on 01/08/2026
• John Colantuoni from Jefferies set a target price of $12.5 on 12/11/2025
• Lloyd Walmsley from Mizuho set a target price of $17.0 on 11/14/2025
• Naved Khan from B. Riley Securities set a target price of $18.0 on 11/10/2025
• Trevor Young from Barclays set a target price of $13.0 on 11/07/2025
• Ronald Josey from Citigroup set a target price of $19.0 on 08/18/2025
• Stephen Ju from UBS set a target price of $18.0 on 07/28/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$270,000 of STRYKER CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Stroke pathways Medicare extenders for EMS Payment models, coverage decisions and protecting access to innovation Issues related to global supply chains for medical devices Issues related to med tech reimbursement globally Issues related to global supply chains Issues related to reprocessing Issues related to PPE Issues related to prevention of hospital-acquired pneumonia Issues related to rural EMS programs Issues related to digital health Issues related to smoke evacuation in the OR Issues related to employment, training and workplace safety Issues related to school safety"

You can find more data on corporate lobbying on Quiver Quantitative.

SYK Congressional Stock Trading

Members of Congress have traded $SYK stock 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $SYK stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 12/10, 11/18, 10/17 and 0 sales.
• REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 4 times. They made 0 purchases and 4 sales worth up to $165,000 on 11/20, 09/12, 08/25, 07/31.
• REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 10/16.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

SYK Insider Trading Activity

SYK insiders have traded $SYK stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.

Here’s a breakdown of recent trading of $SYK stock by insiders over the last 6 months:

• RONDA E STRYKER has made 0 purchases and 22 sales selling 720,000 shares for an estimated $259,895,796.
• WILLIAM E JR BERRY (VP, Chief Accounting Officer) sold 1,953 shares for an estimated $713,801
• ROBERT S FLETCHER (VP, Chief Legal Officer) sold 1,785 shares for an estimated $701,629
• VIJU MENON (Group President) sold 500 shares for an estimated $195,305
• PRESTON WENDELL WELLS (VP, Chief Financial Officer) sold 165 shares for an estimated $60,370

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SYK Hedge Fund Activity

We have seen 1,000 institutional investors add shares of SYK stock to their portfolio, and 959 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 2,009,275 shares (-28.1%) from their portfolio in Q3 2025, for an estimated $742,768,689
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,372,934 shares (+59.5%) to their portfolio in Q3 2025, for an estimated $507,532,511
• CORIENT PRIVATE WEALTH LLC removed 1,295,848 shares (-57.7%) from their portfolio in Q3 2025, for an estimated $479,036,130
• PRICE T ROWE ASSOCIATES INC /MD/ removed 900,546 shares (-7.6%) from their portfolio in Q3 2025, for an estimated $332,904,839
• ROYAL BANK OF CANADA added 876,538 shares (+35.6%) to their portfolio in Q3 2025, for an estimated $324,029,802
• SQUAREPOINT OPS LLC added 757,411 shares (+3842.4%) to their portfolio in Q3 2025, for an estimated $279,992,124
• ALLIANCEBERNSTEIN L.P. added 741,542 shares (+13.3%) to their portfolio in Q3 2025, for an estimated $274,125,831

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SYK Analyst Ratings

Wall Street analysts have issued reports on $SYK in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 11/14/2025
• Wells Fargo issued a "Overweight" rating on 11/14/2025
• Barclays issued a "Overweight" rating on 10/22/2025
• Evercore ISI Group issued a "Outperform" rating on 10/07/2025
• Needham issued a "Buy" rating on 08/01/2025

To track analyst ratings and price targets for SYK, check out Quiver Quantitative's $SYK forecast page.

SYK Price Targets

Multiple analysts have issued price targets for $SYK recently. We have seen 10 analysts offer price targets for $SYK in the last 6 months, with a median target of $430.0.

Here are some recent targets:

• Lee Hambright from Bernstein set a target price of $465.0 on 01/09/2026
• David Turkaly from Citizens set a target price of $440.0 on 12/19/2025
• Richard Newitter from Truist Securities set a target price of $392.0 on 12/18/2025
• Joanne Wuensch from Citigroup set a target price of $420.0 on 12/11/2025
• Larry Biegelsen from Wells Fargo set a target price of $456.0 on 11/14/2025
• Ryan Zimmerman from BTIG set a target price of $410.0 on 11/14/2025
• Mike Matson from Needham set a target price of $448.0 on 11/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$250,000 of ASHBRITT INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"No bill was filed. Issues related to disaster recovery."

You can find more data on corporate lobbying on Quiver Quantitative.

ITT Congressional Stock Trading

Members of Congress have traded $ITT stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $ITT stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 12/11 and 1 sale worth up to $15,000 on 11/06.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ITT Insider Trading Activity

ITT insiders have traded $ITT stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $ITT stock by insiders over the last 6 months:

• LUCA SAVI (President and CEO) has made 0 purchases and 4 sales selling 68,026 shares for an estimated $11,230,964.
• EMMANUEL CAPRAIS (Senior Vice President & CFO) sold 5,500 shares for an estimated $1,018,759
• MESA GRAZIANO CHERYL DE (Vice President & CAO) sold 238 shares for an estimated $43,573

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ITT Hedge Fund Activity

We have seen 272 institutional investors add shares of ITT stock to their portfolio, and 239 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO removed 828,277 shares (-15.6%) from their portfolio in Q3 2025, for an estimated $148,062,796
• SELECT EQUITY GROUP, L.P. removed 286,763 shares (-6.8%) from their portfolio in Q3 2025, for an estimated $51,261,753
• BROWN BROTHERS HARRIMAN & CO added 267,585 shares (+86878.2%) to their portfolio in Q3 2025, for an estimated $47,833,494
• MILLENNIUM MANAGEMENT LLC added 212,111 shares (+236.8%) to their portfolio in Q3 2025, for an estimated $37,916,962
• VANGUARD GROUP INC removed 158,074 shares (-2.0%) from their portfolio in Q3 2025, for an estimated $28,257,308
• MACQUARIE GROUP LTD removed 149,831 shares (-19.0%) from their portfolio in Q3 2025, for an estimated $26,783,789
• BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. added 139,666 shares (+36.6%) to their portfolio in Q3 2025, for an estimated $24,966,694

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ITT Analyst Ratings

Wall Street analysts have issued reports on $ITT in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Keybanc issued a "Overweight" rating on 10/30/2025
• Citigroup issued a "Buy" rating on 10/30/2025
• TD Cowen issued a "Buy" rating on 10/02/2025
• B of A Securities issued a "Buy" rating on 09/16/2025
• UBS issued a "Buy" rating on 09/02/2025
• DA Davidson issued a "Buy" rating on 08/04/2025
• Stifel issued a "Buy" rating on 08/01/2025

To track analyst ratings and price targets for ITT, check out Quiver Quantitative's $ITT forecast page.

ITT Price Targets

Multiple analysts have issued price targets for $ITT recently. We have seen 8 analysts offer price targets for $ITT in the last 6 months, with a median target of $206.5.

Here are some recent targets:

• Matt Summerville from DA Davidson set a target price of $215.0 on 12/08/2025
• Vladimir Bystricky from Citigroup set a target price of $225.0 on 10/30/2025
• Jeffrey D. Hammond from Keybanc set a target price of $215.0 on 10/30/2025
• Nathan Jones from Stifel set a target price of $203.0 on 10/20/2025
• Joseph Giordano from TD Cowen set a target price of $190.0 on 10/02/2025
• Andrew Obin from B of A Securities set a target price of $210.0 on 09/16/2025
• Damian Karas from UBS set a target price of $200.0 on 09/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$360,000 of AMERICAN ELECTRIC POWER COMPANY INC. AND AFFILIATED CORPORATIONS lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY26 National Defense Authorization Act H.R. 1- The One Big Beautiful Bill Act; H.R. 2872, the RESILIENCE Act of 2025; S. 448, the CIRCUIT Act; Resiliency issues generally; Distribution transformer issues generally; Transmission and distribution issues generally; S. 1337- Cybersecurity Information Sharing Extension Act; Counter-UAS legislation; S. 1875 - Streamlining Federal Cybersecurity Regulations Act of 2025; Cyber incident reporting generally; Cyber regulatory harmonization generally; Cybersecurity Information Sharing Act of 2015 reauthorization; Issues Related to Critical Infrastructure Partnership Advisory Council; H.R.__ - Energy Threat Analysis Center Act of 2026; H.R.__ - SECURE Grid Act H.R.__ - Pipeline Cybersecurity Preparedness Act H.R. 5079 Widespread Information Management for the Welfare of Infrastructure and Government Act Infrastructure Investment and Jobs Act; H.R. 4552/S. 2465, Transportation, Housing and Urban Development, and Related Agencies Act, 2026; H.R. 5371- Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Extension Act, 2026; H.R. 4553, Energy and Water Development and Related Agencies Act, 2026; H.R. 4754/S. 2431, Department of Interior, Environment, and Related Agencies Act, 2026; H.R. 5342/S.2354, Commerce, Justice, Science, and Related Agencies Act, 2026; H.R. 5304/S. 2587, Departments of Labor, Health and Human Services, and Education, and Related Agencies Act, 2026; H.R. 4213, Department of Homeland Security Act, 2026; H.R. 4016/S. 2572, Department of Defense Act, 2026; Energy R&D funding; LIHEAP Issues generally; Disaster supplemental funding general H.R. 3616, Reliable Power Act H.R. 1047, Grid Power Act H.R. 3632, Power Plant Reliability Act H.R. 3638, Electric Supply Chain Act H.R. 3157, State Energy Accountability Act HR. 3628, State Planning for Reliability and Affordability Act H.R. 3657, Hydropower Relicensing Transparency Act H.R. 3015, National Coal Council Reestablishment Act H.R. 3617, Securing Americas Critical Minerals Supply Act H.R. 3062, Promoting Cross-Border Energy Infrastructure Act H.R. 5600, SPEED and Reliability Act H.R. 1355, Weatherization Enhancement and Readiness Act H.R. 4503, ePermit Act H.R. 3843, Baseload Reliability Protection Act Draft legislation on transmission; Draft legislation on permitting reform; Draft legislation on permitting certainty; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; Energy security issues generally; Energy Efficiency generally; Issues related to energy grid supply chain; Issues related to energy sector impacts from tariff policies; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers; Draft legislation related to electric grid/energy infrastructure cybersecurity; H.R.__ - Energy Emergency Leadership Act H.R. 471/S. 1462, the Fix Our Forest Act; H.R. 4776, SPEED Act H.R. 161, New Source Review Permitting Improvement Act H.R. 753 Fire Improvement and Reforming Exceptional Events Act (FIRE) Act H.R. 573, Studying NEPAs Impact on Projects Act H.R. 161, New Source Review Permitting Act Conservation regulations at the Bureau of Land Management; Wildfires and other natural disasters; EPA regulations on Clean Air Act Section 111 d and b; EPA regulations generally; Good Neighbor Rule; Coal combustion residuals; Effluent Limitation Guidelines; Draft legislation related to the Federal Permitting Improvement Steering Council; Draft legislation on the Clean Air Act; Rights-of-way; Categorical exclusions; Siting and permitting generally; National Environmental Policy Act; Clean Water Act generally; Endangered Species Act generally; Power demand generally; National Historic Preservation Act generally; Water Resources Development Act generally; Clean Air Act generally H.R. __ - Fixing Emergency Management for Americans Act (FEMA) Act of 2025 Issues Related to Beyond Visual Line of Sight rulemaking; Issues related to Section 2209 rulemaking; Issues related to drone supply chains/Chinese drones Spectrum Issues generally; 811 locate services issues generally"

You can find more data on corporate lobbying on Quiver Quantitative.

AEP Congressional Stock Trading

Members of Congress have traded $AEP stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $AEP stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 1 purchase worth up to $15,000 on 09/22 and 2 sales worth up to $30,000 on 11/03.
• REPRESENTATIVE RICK LARSEN purchased up to $15,000 on 10/06.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AEP Insider Trading Activity

AEP insiders have traded $AEP stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $AEP stock by insiders over the last 6 months:

• BENJAMIN G S III FOWKE has made 0 purchases and 5 sales selling 25,000 shares for an estimated $2,874,050.
• KELLY J FERNEAU (Executive Vice President) has made 0 purchases and 2 sales selling 4,434 shares for an estimated $496,573.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AEP Hedge Fund Activity

We have seen 906 institutional investors add shares of AEP stock to their portfolio, and 571 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• NOMURA HOLDINGS INC removed 4,554,461 shares (-98.1%) from their portfolio in Q3 2025, for an estimated $512,376,862
• BARCLAYS PLC added 3,732,241 shares (+54.6%) to their portfolio in Q3 2025, for an estimated $419,877,112
• LAZARD ASSET MANAGEMENT LLC removed 2,907,961 shares (-90.3%) from their portfolio in Q3 2025, for an estimated $327,145,612
• VICTORY CAPITAL MANAGEMENT INC added 2,763,328 shares (+105.6%) to their portfolio in Q3 2025, for an estimated $310,874,400
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,894,521 shares (+71.5%) to their portfolio in Q3 2025, for an estimated $213,133,612
• ZIMMER PARTNERS, LP removed 1,656,798 shares (-64.9%) from their portfolio in Q3 2025, for an estimated $186,389,775
• ASSENAGON ASSET MANAGEMENT S.A. added 1,529,662 shares (+357.5%) to their portfolio in Q4 2025, for an estimated $176,385,325

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AEP Analyst Ratings

Wall Street analysts have issued reports on $AEP in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 11/17/2025
• Evercore ISI Group issued a "Outperform" rating on 10/30/2025
• Wells Fargo issued a "Overweight" rating on 10/30/2025
• Morgan Stanley issued a "Overweight" rating on 10/30/2025
• UBS issued a "Sell" rating on 10/10/2025
• Raymond James issued a "Outperform" rating on 07/31/2025

To track analyst ratings and price targets for AEP, check out Quiver Quantitative's $AEP forecast page.

AEP Price Targets

Multiple analysts have issued price targets for $AEP recently. We have seen 13 analysts offer price targets for $AEP in the last 6 months, with a median target of $125.0.

Here are some recent targets:

• Shahriar Pourreza from Wells Fargo set a target price of $140.0 on 01/20/2026
• Ross Fowler from B of A Securities set a target price of $122.0 on 01/12/2026
• William Appicelli from UBS set a target price of $107.0 on 12/17/2025
• Jeremy Tonet from JP Morgan set a target price of $125.0 on 12/12/2025
• Julien Dumoulin-Smith from Jefferies set a target price of $137.0 on 11/17/2025
• Ryan Levine from Citigroup set a target price of $132.0 on 10/31/2025
• James Thalacker from BMO Capital set a target price of $126.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$240,000 of ETSY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Bolster policy efforts to enhance the creative economy and development of jobs in the arts by supporting artists, entrepreneurs and workers in their businesses, accessing federal resources and funding, and by expanding their networks with local communities. Issues related to enabling small and microbusinesses to export their goods, including de minimis customs exemptions, trade facilitation, simplification and harmonization of customs and duties requirements, and digital trade issues that enable platforms to offer services globally, such as intermediary liability protections and digital service taxes. Advocated for tax simplification and meaningful exemptions for small and micro businesses and opportunities to build greater economic and financial security for the self employed. New 1099K reporting requirements and implications for the self-employed and micro businesses: SNOOP Act; Saving Gig Economy Taxpayers Act; and Red Tape Reduction Act. Supported efforts to provide portable benefits to independent workers and the self-employed. Promoted caregiving provisions including paid family and medical leave, paid parental leave, an expanded child tax credit and access to affordable childcare. N/A Advocated on issues related to third party marketplace liability, copyright and trademark infringement and issues related to intermediary liability. Shared information on Section 512 of the DMCA and opportunities to improve protections for small creators. Raised concerns for how SHOP SAFE Act would negatively impact small creators. Section 230 of the Communications Decency Act and online child safety. Shared relevant information with policy makers about Etsys approach to setting and enforcing policies, as well as content moderation tools and strategies, to inform policy discussions related to platform responsibility and liability. Engaged on H.R. 3149 / S. 1586 - App Store Accountability Act. Supported efforts to ensure microbusinesses and businesses had access to affordable childcare, an expanded child tax credit, paid parental leave, paid family and medical leave, portable benefits and expanded EITC. Advocated for appropriate funding and sensible electrification of USPS fleet to ensure this vital service remains affordable, sustainable and reliable for Etsy sellers. Shared relevant information with policy makers about Etsy's approach to setting and enforcing trust and safety policies, to inform policy discussions related to platform responsibility, the sale of counterfeit products on third party marketplaces and product liability. Country of Origin Online Labeling (COOL) Act."

You can find more data on corporate lobbying on Quiver Quantitative.

ETSY Insider Trading Activity

ETSY insiders have traded $ETSY stock on the open market 46 times in the past 6 months. Of those trades, 0 have been purchases and 46 have been sales.

Here’s a breakdown of recent trading of $ETSY stock by insiders over the last 6 months:

• JOSH SILVERMAN has made 0 purchases and 21 sales selling 619,996 shares for an estimated $39,670,707.
• MERILEE BUCKLEY (CHIEF ACCOUNTING OFFICER) has made 0 purchases and 6 sales selling 23,280 shares for an estimated $1,398,632.
• GOYAL KRUTI PATEL (President&Chief Growth Officer) has made 0 purchases and 6 sales selling 19,629 shares for an estimated $1,284,892.
• M MICHELE BURNS sold 14,464 shares for an estimated $908,628
• MELISSA REIFF sold 6,909 shares for an estimated $406,871
• RICHARD EDWARD III COLBURN (Chief Product & Tech Officer) has made 0 purchases and 2 sales selling 4,597 shares for an estimated $273,767.
• BRADLEY MINOR (Chief Marketing Officer) sold 3,095 shares for an estimated $178,921
• NICHOLAS DANIEL (CHIEF PRODUCT OFFICER) has made 0 purchases and 3 sales selling 3,000 shares for an estimated $165,617.
• CHARLES ANDREW BALLARD sold 2,400 shares for an estimated $149,808
• MARLA J BLOW has made 0 purchases and 4 sales selling 750 shares for an estimated $46,064.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ETSY Hedge Fund Activity

We have seen 241 institutional investors add shares of ETSY stock to their portfolio, and 281 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• NOMURA HOLDINGS INC removed 3,971,880 shares (-90.8%) from their portfolio in Q3 2025, for an estimated $263,693,113
• LONE PINE CAPITAL LLC added 3,880,316 shares (+inf%) to their portfolio in Q3 2025, for an estimated $257,614,179
• HOLOCENE ADVISORS, LP removed 2,238,257 shares (-41.9%) from their portfolio in Q3 2025, for an estimated $148,597,882
• POINT72 ASSET MANAGEMENT, L.P. added 1,840,590 shares (+inf%) to their portfolio in Q3 2025, for an estimated $122,196,770
• RENAISSANCE TECHNOLOGIES LLC removed 1,643,400 shares (-21.5%) from their portfolio in Q3 2025, for an estimated $109,105,326
• AQR CAPITAL MANAGEMENT LLC removed 1,485,788 shares (-33.6%) from their portfolio in Q3 2025, for an estimated $98,641,465
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,283,604 shares (-34.8%) from their portfolio in Q3 2025, for an estimated $85,218,469

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ETSY Analyst Ratings

Wall Street analysts have issued reports on $ETSY in the last several months. We have seen 6 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 11/12/2025
• Canaccord Genuity issued a "Buy" rating on 10/30/2025
• Truist Securities issued a "Buy" rating on 10/30/2025
• Wells Fargo issued a "Underweight" rating on 10/30/2025
• Raymond James issued a "Outperform" rating on 10/30/2025
• Goldman Sachs issued a "Sell" rating on 10/30/2025
• Guggenheim issued a "Buy" rating on 09/18/2025

To track analyst ratings and price targets for ETSY, check out Quiver Quantitative's $ETSY forecast page.

ETSY Price Targets

Multiple analysts have issued price targets for $ETSY recently. We have seen 20 analysts offer price targets for $ETSY in the last 6 months, with a median target of $68.0.

Here are some recent targets:

• Deepak Mathivanan from Cantor Fitzgerald set a target price of $55.0 on 01/08/2026
• Marvin Fong from BTIG set a target price of $74.0 on 12/30/2025
• Scott Devitt from Wedbush set a target price of $66.0 on 12/19/2025
• Ygal Arounian from Citigroup set a target price of $60.0 on 12/15/2025
• John Colantuoni from Jefferies set a target price of $60.0 on 12/11/2025
• Eric Sheridan from Goldman Sachs set a target price of $57.0 on 10/30/2025
• Lauren Schenk from Morgan Stanley set a target price of $65.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$340,000 of KYNDRYL INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Workforce Development, Skilling, White House AI Education Pledge White House AI Action Plan; AI Regulation Monitoring developments related to H-1B processing"

You can find more data on corporate lobbying on Quiver Quantitative.

KD Congressional Stock Trading

Members of Congress have traded $KD stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $KD stock by members of Congress over the last 6 months:

• REPRESENTATIVE DWIGHT EVANS sold up to $0 on 10/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

KD Insider Trading Activity

KD insiders have traded $KD stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $KD stock by insiders over the last 6 months:

• VINEET KHURANA (SVP & Global Controller) sold 6,641 shares for an estimated $177,275

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

KD Hedge Fund Activity

We have seen 281 institutional investors add shares of KD stock to their portfolio, and 295 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AQR CAPITAL MANAGEMENT LLC added 3,326,025 shares (+386.2%) to their portfolio in Q3 2025, for an estimated $99,880,530
• NEUBERGER BERMAN GROUP LLC added 2,778,930 shares (+22.5%) to their portfolio in Q3 2025, for an estimated $83,451,267
• FMR LLC removed 2,590,205 shares (-8.8%) from their portfolio in Q3 2025, for an estimated $77,783,856
• SOUND SHORE MANAGEMENT INC /CT/ added 2,035,069 shares (+inf%) to their portfolio in Q3 2025, for an estimated $61,113,122
• VANGUARD GROUP INC added 1,619,048 shares (+6.1%) to their portfolio in Q3 2025, for an estimated $48,620,011
• WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,059,698 shares (-44.6%) from their portfolio in Q3 2025, for an estimated $31,822,730
• DME CAPITAL MANAGEMENT, LP added 1,032,330 shares (+31.2%) to their portfolio in Q3 2025, for an estimated $31,000,869

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

KD Analyst Ratings

Wall Street analysts have issued reports on $KD in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 11/26/2025
• JP Morgan issued a "Overweight" rating on 11/06/2025

To track analyst ratings and price targets for KD, check out Quiver Quantitative's $KD forecast page.

KD Price Targets

Multiple analysts have issued price targets for $KD recently. We have seen 3 analysts offer price targets for $KD in the last 6 months, with a median target of $30.0.

Here are some recent targets:

• Jonathan Lee from Guggenheim set a target price of $30.0 on 11/26/2025
• Tien-Tsin Huang from JP Morgan set a target price of $40.0 on 11/06/2025
• James Faucette from Morgan Stanley set a target price of $30.0 on 09/26/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of FIREFLY AEROSPACE INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

FLY Insider Trading Activity

FLY insiders have traded $FLY stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $FLY stock by insiders over the last 6 months:

• GP, LLC AEROEQUITY purchased 11,111 shares for an estimated $499,995
• PAMELA JOYCE BRADEN purchased 8,888 shares for an estimated $399,960
• KIRK MICHAEL KONERT purchased 3,333 shares for an estimated $149,985
• THOMAS HANSUELI ZURBUCHEN purchased 800 shares for an estimated $36,000
• JONATHAN DONALD LUSCZAKOSKI purchased 266 shares for an estimated $11,970

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FLY Hedge Fund Activity

We have seen 120 institutional investors add shares of FLY stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AE INDUSTRIAL PARTNERS, LP added 36,284,543 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,063,862,800
• PRICE T ROWE ASSOCIATES INC /MD/ added 1,861,340 shares (+inf%) to their portfolio in Q3 2025, for an estimated $54,574,488
• VANGUARD GROUP INC added 1,821,598 shares (+inf%) to their portfolio in Q3 2025, for an estimated $53,409,253
• HUDSON BAY CAPITAL MANAGEMENT LP added 1,811,811 shares (+inf%) to their portfolio in Q3 2025, for an estimated $53,122,298
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,407,595 shares (+inf%) to their portfolio in Q3 2025, for an estimated $41,270,685
• ILEX CAPITAL PARTNERS (UK) LLP added 1,316,471 shares (+inf%) to their portfolio in Q3 2025, for an estimated $38,598,929
• CAPITAL WORLD INVESTORS added 1,205,209 shares (+inf%) to their portfolio in Q3 2025, for an estimated $35,336,727

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

FLY Analyst Ratings

Wall Street analysts have issued reports on $FLY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 11/25/2025
• Deutsche Bank issued a "Buy" rating on 11/13/2025
• Roth Capital issued a "Buy" rating on 11/13/2025
• Jefferies issued a "Buy" rating on 09/02/2025
• Cantor Fitzgerald issued a "Overweight" rating on 09/02/2025

To track analyst ratings and price targets for FLY, check out Quiver Quantitative's $FLY forecast page.

FLY Price Targets

Multiple analysts have issued price targets for $FLY recently. We have seen 8 analysts offer price targets for $FLY in the last 6 months, with a median target of $31.0.

Here are some recent targets:

• Anthony Valentini from Goldman Sachs set a target price of $32.0 on 01/20/2026
• Seth Seifman from JP Morgan set a target price of $28.0 on 11/25/2025
• Kristine Liwag from Morgan Stanley set a target price of $27.0 on 11/17/2025
• Edison Yu from Deutsche Bank set a target price of $30.0 on 11/13/2025
• Suji Desilva from Roth Capital set a target price of $30.0 on 11/13/2025
• Sheila Kahyaoglu from Jefferies set a target price of $60.0 on 09/02/2025
• Colin Canfield from Cantor Fitzgerald set a target price of $65.0 on 09/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$820,000 of COINBASE INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 3633: DIGITAL ASSET MARKET CLARITY ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS RELATED TO THE IMPLMENTATION OF P.L. 119-27 (S. 1582): GENIUS ACT GENERAL DISCUSSIONS RELATED TO CRYPTO POLICY AND MARKET STRUCTURE GENERAL DISCUSSIONS RELATED TO CONSUMER FINANCIAL PAYMENT PROTECTIONS AS APPLIED TO DIGITAL ASSETS S. 2207: A BILL TO AMEND THE INTERNAL REVENUE CODE OF 1986 TO REFORM THE TREATMENT OF DIGITAL ASSETS; ALL PROVISIONS GENERAL DISCUSSIONS RELATED TO DIGITAL ASSET TAX AND DIGITAL ASSET TAX TREATMENT H.R. 3633: DIGITAL ASSET MARKET CLARITY ACT OF 2025; PROVISIONS RELATED TO DIGITAL ASSET MARKET STRUCTURE GENERAL DISCUSSIONS RELATED TO P.L. 119-27 (S. 1582): GENIUS ACT GENERAL DISCUSSIONS RELATED TO CONSUMER FINANCIAL PAYMENT PROTECTIONS AS APPLIED TO DIGITAL ASSETS GENERAL DISCUSSIONS RELATED TO THE IMPLMENTATION OF P.L. 119-27 (S. 1582): GENIUS ACT GENERAL DISCUSSIONS RELATED TO DIGITAL ASSET MARKET STRUCTURE"

You can find more data on corporate lobbying on Quiver Quantitative.

COIN Congressional Stock Trading

Members of Congress have traded $COIN stock 6 times in the past 6 months. Of those trades, 4 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $COIN stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 3 purchases worth up to $45,000 on 11/18, 10/17, 10/09 and 2 sales worth up to $30,000 on 12/24, 12/19.
• REPRESENTATIVE TIM MOORE purchased up to $50,000 on 09/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

COIN Insider Trading Activity

COIN insiders have traded $COIN stock on the open market 238 times in the past 6 months. Of those trades, 0 have been purchases and 238 have been sales.

Here’s a breakdown of recent trading of $COIN stock by insiders over the last 6 months:

• BRIAN ARMSTRONG (Chairman and CEO) has made 0 purchases and 65 sales selling 400,000 shares for an estimated $118,166,379.
• FREDERICK ERNEST III EHRSAM has made 0 purchases and 33 sales selling 370,564 shares for an estimated $114,289,259.
• EMILIE CHOI (President & COO) has made 0 purchases and 13 sales selling 100,000 shares for an estimated $31,087,593.
• PAUL GREWAL (Chief Legal Officer) has made 0 purchases and 41 sales selling 48,370 shares for an estimated $14,499,255.
• ALESIA J HAAS (Chief Financial Officer) has made 0 purchases and 18 sales selling 41,627 shares for an estimated $12,213,726.
• FREDERICK R WILSON has made 0 purchases and 41 sales selling 30,000 shares for an estimated $7,950,185.
• LAWRENCE J BROCK (Chief People Officer) has made 0 purchases and 23 sales selling 11,805 shares for an estimated $3,316,918.
• JENNIFER N. JONES (Chief Accounting Officer) has made 0 purchases and 4 sales selling 5,281 shares for an estimated $1,455,314.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

COIN Hedge Fund Activity

We have seen 786 institutional investors add shares of COIN stock to their portfolio, and 508 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 2,007,930 shares (+8.3%) to their portfolio in Q3 2025, for an estimated $677,656,295
• A16Z PERENNIAL MANAGEMENT, L.P. removed 1,530,352 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $516,478,496
• BLACKROCK, INC. added 1,030,235 shares (+6.8%) to their portfolio in Q3 2025, for an estimated $347,694,010
• JANE STREET GROUP, LLC removed 872,494 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $294,458,000
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 871,968 shares (+69.2%) to their portfolio in Q3 2025, for an estimated $294,280,480
• RENAISSANCE TECHNOLOGIES LLC removed 763,900 shares (-87.1%) from their portfolio in Q3 2025, for an estimated $257,808,611
• ARTISAN PARTNERS LIMITED PARTNERSHIP added 665,688 shares (+inf%) to their portfolio in Q3 2025, for an estimated $224,663,043

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

COIN Analyst Ratings

Wall Street analysts have issued reports on $COIN in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Buy" rating on 01/08/2026
• BTIG issued a "Buy" rating on 12/18/2025
• Deutsche Bank issued a "Buy" rating on 12/17/2025
• Monness, Crespi, Hardt issued a "Buy" rating on 11/10/2025
• Rosenblatt issued a "Buy" rating on 10/31/2025
• Needham issued a "Buy" rating on 10/31/2025
• HC Wainwright & Co. issued a "Buy" rating on 10/31/2025

To track analyst ratings and price targets for COIN, check out Quiver Quantitative's $COIN forecast page.

COIN Price Targets

Multiple analysts have issued price targets for $COIN recently. We have seen 20 analysts offer price targets for $COIN in the last 6 months, with a median target of $372.5.

Here are some recent targets:

• Patrick Moley from Piper Sandler set a target price of $270.0 on 01/14/2026
• Owen Lau from Oppenheimer set a target price of $370.0 on 01/12/2026
• Benjamin Budish from Barclays set a target price of $258.0 on 01/08/2026
• Jason Kupferberg from B of A Securities set a target price of $340.0 on 01/08/2026
• Andrew Harte from BTIG set a target price of $420.0 on 12/18/2025
• Brett Knoblauch from Cantor Fitzgerald set a target price of $320.0 on 12/18/2025
• Brian Bedell from Deutsche Bank set a target price of $340.0 on 12/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,010,000 of IHEARTMEDIA INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HR 979/S.315,the "AM Radio for Every Vehicle Act." Congressional oversight and legislative proposals regarding data privacy. Congressional oversight and legislative proposals regarding the FCC's proceeding on EAS modernization (PS Docket No. 25-224). Congressional oversight and legislative proposals regarding the FCC's proceeding on foreign adversary interests (GN Docket No. 25-166). Congressional oversight and legislative proposals regarding the FCC's proceeding on foreign ownership interests (GN Docket No. 25-149). H. Con. Res. 12/S. Con. Res. 8, "Supporting the Local Radio Freedom Act." HR.861/S.326, "American Music Fairness Act." Congressional oversight and legislative proposals regarding Copyright Royalty Board rate setting. Congressional oversight and legislative proposals regarding copyright-related concerns with artificial intelligence. Preserving the deductibility of advertising expenses. H.R.6335, the "Education Not Endless Scrolling Act.""

You can find more data on corporate lobbying on Quiver Quantitative.

IHRT Insider Trading Activity

IHRT insiders have traded $IHRT stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $IHRT stock by insiders over the last 6 months:

• ROBERT W PITTMAN (Chairman and CEO) purchased 117,371 shares for an estimated $256,972

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

IHRT Hedge Fund Activity

We have seen 57 institutional investors add shares of IHRT stock to their portfolio, and 53 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 1,715,176 shares (+40.3%) to their portfolio in Q3 2025, for an estimated $4,922,555
• SCHONFELD STRATEGIC ADVISORS LLC removed 1,000,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,870,000
• HELIX PARTNERS MANAGEMENT LP removed 784,016 shares (-72.3%) from their portfolio in Q3 2025, for an estimated $2,250,125
• MILLENNIUM MANAGEMENT LLC added 768,107 shares (+inf%) to their portfolio in Q3 2025, for an estimated $2,204,467
• ARISTEIA CAPITAL, L.L.C. removed 714,347 shares (-38.3%) from their portfolio in Q3 2025, for an estimated $2,050,175
• LOOMIS SAYLES & CO L P removed 707,912 shares (-48.6%) from their portfolio in Q3 2025, for an estimated $2,031,707
• MORGAN STANLEY added 661,994 shares (+147.3%) to their portfolio in Q3 2025, for an estimated $1,899,922

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

IHRT Price Targets

Multiple analysts have issued price targets for $IHRT recently. We have seen 2 analysts offer price targets for $IHRT in the last 6 months, with a median target of $4.25.

Here are some recent targets:

• Stephen Laws from Goldman Sachs set a target price of $3.5 on 01/09/2026
• Jessica Reif Cohen from B of A Securities set a target price of $5.0 on 11/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,710,000 of SOUTHERN COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Climate change issues, generally; Environmental regulation, generally; Clean Water Act, generally; Nationwide Permit Program, generally (Clean Water Act Section 404); NEPA Phase II Proposed Rule and NEPA issues, generally; ESA regulations, generally; Issues related to wildfires, generally; Inflation Reduction Act implementation, generally; One Big Beautiful Bill Act implementation, generally; None. Drone/UAV issues, generally; Issues related to EV infrastructure, generally; None. Middle-mile broadband infrastructure issues, generally; Spectrum issues, generally, including the FCC's 6 GHz spectrum proposal and Cruz-Thune spectrum pipeline bill; Pole attachment issues, generally; None. Climate change issues, generally; Environmental regulation, generally (Effluent Limitations Guidelines; Good Neighbor Ozone Transport; CAA Sec. 111 rulemaking) DOE Distribution Transformer Rule; Energy efficiency, generally; Grid enhancing technologies, generally; Issues related to FERCs transmission planning and cost allocation rule (Order 1920); Issues related to FERCs regional transmission organizations, generally; Issues related to deregulation, generally; DOE Loan Program Office issues, generally (1706); Issues related to transmission legislation, generally; Issues related to grid enhancing technologies, generally; Issues related to Natural gas infrastructure development, generally; Issues related to Energy infrastructure development, generally; Issues related to FERC nominations, generally; Issues related to S.2651, the SITE Act; Issues related to Building American Energy Security Act of 2023; Issues related to regional transmission organizations, generally; Issues related to deregulation generally; Issues related to interconnection, generally; Issues related to DOE Loan Program Office, generally; Issues related to wildfires, generally; H.R. 7624, Advancing Grid-Enhancing Technologies Act of 2024; H.R. 4476, PURPA Modernization Act of 2017; H.R. 1897, ESA Amendments of 2025; S.1449 RESTART Act; Issues related to HR 1, generally; Issues related to NEPA and permitting reform, generally; Issues related to Yucca Mountain used fuel repository; Issues related to used fuel management; Issues related to consent-based siting generally; Issues related to AP1000 technology generally; Issues related to Accident Tolerant Fuel program; Issues related to advanced nuclear technology; Issues related to DOE Advanced Reactor Development Program, generally; Issues related to small modular reactors (SMRs) in general; Issues related to natural gas appliances; Issues related to DOE energy efficiency standards for electric distribution transformers; DOE new nuclear R&D programs, generally; NRC fee issues, generally; Issues related to NRC nominees in general; Issues related to the NRC decision on Subsequent License Renewal; Issues related to Subsequent License Renewal, generally; Issues related to nuclear uprates, generally; Issues related to nuclear fuels; Issues related to HAELU fuel; Issues related to distribution transformers, generally; Issues related to Transmission legislation, generally; Issues related to Energy infrastructure development, generally; Issues related to permitting reform, generally; Issues related to new nuclear risk mitigation, generally; The ADVANCE Act, P.L. 118-67; National Science Foundation Regional Innovation Engines; The SPEED and Reliability Act, generally; The BIG WIRES Act, generally None. Budget reconciliation, generally; Energy R&D funding; Low Income Home Energy Assistance Program (LIHEAP) funding; FY2025 Energy and Water Development and Related Agencies Appropriations bills, generally; Issues related to the Department of Government Efficiency, generally;"

You can find more data on corporate lobbying on Quiver Quantitative.

SO Congressional Stock Trading

Members of Congress have traded $SO stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $SO stock by members of Congress over the last 6 months:

• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 12/02.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 08/28.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

SO Insider Trading Activity

SO insiders have traded $SO stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $SO stock by insiders over the last 6 months:

• BRYAN D ANDERSON (EVP) sold 6,206 shares for an estimated $582,308
• STERLING A JR. SPAINHOUR (EVP & CLO) sold 2,380 shares for an estimated $226,147

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SO Hedge Fund Activity

We have seen 1,052 institutional investors add shares of SO stock to their portfolio, and 850 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS added 25,567,431 shares (+320.3%) to their portfolio in Q3 2025, for an estimated $2,423,025,435
• PRICE T ROWE ASSOCIATES INC /MD/ added 11,496,694 shares (+65.6%) to their portfolio in Q3 2025, for an estimated $1,089,541,690
• CAPITAL INTERNATIONAL INVESTORS removed 6,234,937 shares (-24.1%) from their portfolio in Q3 2025, for an estimated $590,884,979
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 5,016,263 shares (+77.9%) to their portfolio in Q3 2025, for an estimated $475,391,244
• CITADEL ADVISORS LLC removed 1,661,394 shares (-70.3%) from their portfolio in Q3 2025, for an estimated $157,450,309
• GOLDMAN SACHS GROUP INC removed 1,323,276 shares (-18.3%) from their portfolio in Q3 2025, for an estimated $125,406,866
• EXODUSPOINT CAPITAL MANAGEMENT, LP removed 1,207,378 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $114,423,213

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SO Analyst Ratings

Wall Street analysts have issued reports on $SO in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Underweight" rating on 01/20/2026
• Keybanc issued a "Underweight" rating on 12/12/2025

To track analyst ratings and price targets for SO, check out Quiver Quantitative's $SO forecast page.

SO Price Targets

Multiple analysts have issued price targets for $SO recently. We have seen 12 analysts offer price targets for $SO in the last 6 months, with a median target of $93.0.

Here are some recent targets:

• Shahriar Pourreza from Wells Fargo set a target price of $84.0 on 01/20/2026
• Nicholas Campanella from Barclays set a target price of $88.0 on 01/15/2026
• Daniel Ford from UBS set a target price of $94.0 on 12/17/2025
• Jeremy Tonet from JP Morgan set a target price of $93.0 on 12/15/2025
• Julien Dumoulin-Smith from Jefferies set a target price of $93.0 on 12/15/2025
• Stephen D'Ambrisi from RBC Capital set a target price of $99.0 on 12/12/2025
• Sophie Karp from Keybanc set a target price of $76.0 on 12/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,100,000 of SANOFI US SERVICES INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"340B: Biologic/Small molecule drug negotiation eligibility within HR 7174/S.832 EPIC Act; CDC Type 1 Diabetes Awareness and Education within LHHS appropriations; Clinical Trial Diversity; Copay Accumulators; COPD Education and Awareness within LHHS appropriations; COPD Research Funding within LHHS appropriations; Delinking; Drug Price Negotiations - General; Drug Price Negotiations within Inflation Reduction Act; Drug Pricing- General Issues; FDA Drug Development; FDA Issues - General; Issues related to HR 1 One Big Beautiful Bill; HR 830 (118th) HELP Copays Act; HR 2880: Protecting Patients Against PBM Abuses Act; HR 5143 (118th) Vaccines Access Improvement Act; HR 5376: Inflation Reduction Act; HRSA - Type 1 Diabetes Screening within LHHS appropriations; Influenza Vaccines; Insurance Design; Intellectual Property; International Reference Pricing; Most Favored Nation; Orphan Drug Negotiation within HR 5539/S 3131 Orphan Cures Act; Out of Pocket Cap; Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization; Pharmacy Benefit Managers (PBM) Reform; Rare Pediatric Priority Review Voucher Program Reauthorization within HR 7834; Rebate Pass Through; Respiratory Syncytial Virus (RSV) Access; Routine Immunization Rates; S. 864 HELP Copays Act: S. 1339 (118th): PBM Reform Act; S. 1375: HELP Copays Act; S. 1542 (118th) DRUG Act; S. 2027: Prescription Information Modernization Act; S.4504 / HR 8698 (118th): SCREEN for Type 1 Diabetes Act; Supply Chain; Tax Credits; Transplant; Vaccine Injury Compensation Program; Vaccines-General Issues. 340B; Medicare Negotiation, and Most Favored Nation. Supply Chain Issues; and Importation issues. Supply Chain issues; and Vaccine Injury Compensation Program. S. 43: Skinny Labels, Big Savings Act; S. 2276 ETHIC Act; and Intellectual Property. Insulin; Taxes- General Issues; Vaccine - General Issues; Pharmacy Benefits Managers (PBMs); and Type 1 Diabetes Screening."

You can find more data on corporate lobbying on Quiver Quantitative.

SNY Congressional Stock Trading

Members of Congress have traded $SNY stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $SNY stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/04 and 1 sale worth up to $15,000 on 09/11.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

SNY Hedge Fund Activity

We have seen 329 institutional investors add shares of SNY stock to their portfolio, and 336 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS removed 8,354,084 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $394,312,764
• INVESCO LTD. removed 3,390,657 shares (-36.9%) from their portfolio in Q3 2025, for an estimated $160,039,010
• DODGE & COX removed 2,786,568 shares (-3.9%) from their portfolio in Q3 2025, for an estimated $131,526,009
• RAYMOND JAMES FINANCIAL INC removed 2,443,717 shares (-41.6%) from their portfolio in Q3 2025, for an estimated $115,343,442
• THRIVENT FINANCIAL FOR LUTHERANS added 2,079,366 shares (+1722.2%) to their portfolio in Q3 2025, for an estimated $98,146,075
• MILLENNIUM MANAGEMENT LLC added 1,319,379 shares (+1151.8%) to their portfolio in Q3 2025, for an estimated $62,274,688
• BNP PARIBAS FINANCIAL MARKETS added 859,246 shares (+422.1%) to their portfolio in Q3 2025, for an estimated $40,556,411

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SNY Analyst Ratings

Wall Street analysts have issued reports on $SNY in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 10/27/2025
• Morgan Stanley issued a "Overweight" rating on 09/08/2025
• Deutsche Bank issued a "Buy" rating on 09/02/2025

To track analyst ratings and price targets for SNY, check out Quiver Quantitative's $SNY forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,700,000 of FEDEX CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R.574/S.187 - ALIGN Act Legislative monitoring for tax credits involving EVs, SAFs, and zero emission charging infrastructure Corporate and international tax issues related to the Tax Cuts and Jobs Act H.R.1062 - Growing and Preserving Innovation in America Act of 2025 General monitoring of administration policy and Executive Orders The One Big Beautiful Bill Act H.R.1177/S.492 - Improve and Enhance the Work Opportunity Tax Credit Act H.R.6231/S.3265 - Improve and Enhance the Work Opportunity Tax Credit Act Legislative monitoring of U.S. Postal Service-related issues General monitoring of administration policy and Executive Orders S.1604 - No RTO Act H.R.3004 - USPS SERVES US Act S.986 - STOP Act 2.0 H.R.3011 - USPS Shipping Equity Act H.Res.70/S.Res.147 - Expressing the sense of the House of Representatives that Congress should take all appropriate measures to ensure that the United States Postal Service remains an independent establishment of the Federal Government and is not subject to privatization Porch Pirates Act of 2025 Legislative monitoring of Open Skies Agreements Legislative monitoring of general trade issues including customs modernization, GSP, MTB, IPEF, CBAM, and de minimis Legislative monitoring around China PNTR Foreign Pollution Fee Act of 2025 S.1259/H.R.2653 - Manifest Modernization Act of 2025 H.R.1840 - Closing the De Minimis Loophole Act H.R.805 - End Chinas De Minimis Abuse Act H.R.322 - Import Security and Fairness Act H.R.1504 - China Trade Relations Act of 2025 H.R.694 - Restoring Trade Fairness Act S.206 - Restoring Trade Fairness Act H.R.407 - Prevent Tariff Abuse Act S.956 - Customs Facilitation Act of 2025 H.R.6500 - The AGOA Extension Act H.R.6504 - The Haiti Economic Lift Program Extension Act H.R.4930 - Information Sharing The One Big Beautiful Bill Act General monitoring of administration policy and Executive Orders H.Con.Res.14 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 FY 2026 Transportation, Housing, and Urban Development, and Related Agencies Appropriations bills FY 2026 Homeland Security (DHS) Appropriations General monitoring of administration policy and Executive Orders Legislative monitoring on aviation security and aviation safety issues including all-cargo flight time and duty rules; ATC modernization; and Open Skies agreements General monitoring of administration policy and Executive Orders S.1985 - Safe Operations of Shared Airspace Act of 2025 S.1706 - A bill to require aircraft operating in Class B airspace in the national airspace system to install and operate ADS-B In and ADS-B Out equipment, and for other purposes S.2503 - Rotorcraft Operations Transparency and Oversight Reform Act Transportation Security Reauthorization Act H.R.6086 - Aviation Funding Solvency Act S.1045/H.R.5451/H.R.5455 - Aviation Funding Stability Act of 2025 H.R.2424 - Modern, Clean, and Safe Trucks Act of 2025 H.R.2391 - Strengthening the Supply Chain Through Truck Drivers Incentives Act of 2025 H.R.1659 - Truck Parking Safety Improvement Act H.R.2514 - Trucker Bathroom Access Act H.R.2954/S.1537 - Veterans Transition to Trucking Act of 2025 H.R.5268 - Forum Accountability and Integrity in Roadway Trucking Act (FAIR Act) H.R.1109 - Litigation Transparency Act of 2025 H.R.3512/S.1821 - Tackling Predatory Litigation Funding Act H.R.2662 Staged Accident Fraud Prevention Act of 2025 S.711 - Transportation Freedom Act General monitoring of the DOT English Language Proficiency Rule Legislative monitoring of AV bills, including vehicle data ownership and zero occupant vehicles General monitoring of administration policy and Executive Orders Surface Transportation Reauthorization Draft H.R.3373 - GHOST Act S.345/H.R.850 - Silencers Help Us Save Hearing (SHUSH) Act General monitoring of legislation related to shipping restricted commodities H.R.2853/S.1404 - Combatting Organized Retail Crime Act H.R.20/S.852 - Richard L. Trumka Protecting the Right to Organize Act of 2025 H.R.1962/S.893 - Guaranteeing Overtime For Truckers Act H.R.4366 - Save Local Business Act H.R.5267 - American Franchise Act S.844 - Faster Labor Contracts Act S.2163 - Warehouse Worker Protection Act DOL Independent Contractor Rule NLRB Joint Employer Rule Package Delivery Parity Act Discussion Draft Legislative monitoring of activity related to the Railway Labor Act (RLA) General monitoring of the OSHA Walkaround Rule General monitoring of the OSHA Heat Illness Rule General monitoring of administration policy and Executive Orders Legislative monitoring of H1b visas and critical worker immigration General monitoring of administration policy and Executive Orders Legislative monitoring of consumer privacy issues, vehicle data issues, and AI H.R.1566 - REPAIR Act H.R.1664/S.1492 - Deploying American Blockchains Act of 2025 General monitoring of administration policy and Executive Orders Legislative monitoring of federal contracting issues General monitoring of administration policy and Executive Orders S.382/H.R.925 - Dismantle DEI Act S.2296, the National Defense Authorization Act for FY 2026"

You can find more data on corporate lobbying on Quiver Quantitative.

FDX Congressional Stock Trading

Members of Congress have traded $FDX stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $FDX stock by members of Congress over the last 6 months:

• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $50,000 on 08/28.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

FDX Insider Trading Activity

FDX insiders have traded $FDX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $FDX stock by insiders over the last 6 months:

• JOSHUA COOPER RAMO sold 3,610 shares for an estimated $838,361

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FDX Hedge Fund Activity

We have seen 752 institutional investors add shares of FDX stock to their portfolio, and 785 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VALEO FINANCIAL ADVISORS, LLC removed 3,729,540 shares (-99.6%) from their portfolio in Q3 2025, for an estimated $879,462,827
• CAPITAL INTERNATIONAL INVESTORS removed 3,215,346 shares (-42.7%) from their portfolio in Q3 2025, for an estimated $758,210,740
• VANGUARD GROUP INC added 2,741,723 shares (+13.2%) to their portfolio in Q3 2025, for an estimated $646,525,700
• BOSTON PARTNERS added 1,983,928 shares (+inf%) to their portfolio in Q3 2025, for an estimated $467,830,061
• DODGE & COX added 1,742,666 shares (+12.0%) to their portfolio in Q3 2025, for an estimated $410,938,069
• AQR CAPITAL MANAGEMENT LLC added 1,718,278 shares (+169.2%) to their portfolio in Q3 2025, for an estimated $405,187,135
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,099,745 shares (+68.5%) to their portfolio in Q3 2025, for an estimated $259,330,868

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

FDX Analyst Ratings

Wall Street analysts have issued reports on $FDX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 12/19/2025
• Stifel issued a "Buy" rating on 12/19/2025
• Truist Securities issued a "Buy" rating on 12/19/2025
• Morgan Stanley issued a "Underweight" rating on 12/19/2025
• Jefferies issued a "Buy" rating on 12/19/2025
• Stephens & Co. issued a "Overweight" rating on 12/19/2025
• UBS issued a "Buy" rating on 08/28/2025

To track analyst ratings and price targets for FDX, check out Quiver Quantitative's $FDX forecast page.

FDX Price Targets

Multiple analysts have issued price targets for $FDX recently. We have seen 17 analysts offer price targets for $FDX in the last 6 months, with a median target of $315.0.

Here are some recent targets:

• Oliver Holmes from Rothschild & Co set a target price of $317.0 on 01/21/2026
• David Vernon from Bernstein set a target price of $306.0 on 01/09/2026
• Reed Seay from Stephens & Co. set a target price of $330.0 on 12/19/2025
• Christian Wetherbee from Wells Fargo set a target price of $295.0 on 12/19/2025
• J. Bruce Chan from Stifel set a target price of $328.0 on 12/19/2025
• Brian Ossenbeck from JP Morgan set a target price of $294.0 on 12/19/2025
• Fadi Chamoun from BMO Capital set a target price of $290.0 on 12/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$810,000 of ALLY FINANCIAL INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Proposals regarding financial regulatory reform implementation for consumer financial products. Proposals to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Financial literacy and education efforts. Proposals related to the regulation of deposit accounts. Proposals regarding financial regulatory reform. Proposals regarding consumer financial protection and insurance products regulation. Proposals related to taxation legislation and the impact on financial institutions and bank holding companies, including reporting obligations; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation."

You can find more data on corporate lobbying on Quiver Quantitative.

ALLY Insider Trading Activity

ALLY insiders have traded $ALLY stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ALLY stock by insiders over the last 6 months:

• KATHLEEN L. PATTERSON (Chief HR & Corp Citizenship) sold 29,000 shares for an estimated $1,184,803

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ALLY Hedge Fund Activity

We have seen 282 institutional investors add shares of ALLY stock to their portfolio, and 249 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• THRIVENT FINANCIAL FOR LUTHERANS added 3,798,834 shares (+7915.7%) to their portfolio in Q3 2025, for an estimated $148,914,292
• WELLINGTON MANAGEMENT GROUP LLP added 1,958,201 shares (+19.6%) to their portfolio in Q3 2025, for an estimated $76,761,479
• UBS GROUP AG removed 1,366,557 shares (-38.6%) from their portfolio in Q3 2025, for an estimated $53,569,034
• JPMORGAN CHASE & CO removed 1,320,708 shares (-58.2%) from their portfolio in Q3 2025, for an estimated $51,771,753
• MARSHALL WACE, LLP removed 1,290,880 shares (-97.3%) from their portfolio in Q3 2025, for an estimated $50,602,496
• BLACKROCK, INC. added 1,274,154 shares (+4.9%) to their portfolio in Q3 2025, for an estimated $49,946,836
• POINT72 ASSET MANAGEMENT, L.P. removed 1,269,879 shares (-58.2%) from their portfolio in Q3 2025, for an estimated $49,779,256

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ALLY Analyst Ratings

Wall Street analysts have issued reports on $ALLY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Cowen issued a "Buy" rating on 01/08/2026
• Evercore ISI Group issued a "Outperform" rating on 01/06/2026
• JP Morgan issued a "Overweight" rating on 10/07/2025
• Keefe, Bruyette & Woods issued a "Outperform" rating on 10/01/2025
• Citigroup issued a "Buy" rating on 09/15/2025

To track analyst ratings and price targets for ALLY, check out Quiver Quantitative's $ALLY forecast page.

ALLY Price Targets

Multiple analysts have issued price targets for $ALLY recently. We have seen 10 analysts offer price targets for $ALLY in the last 6 months, with a median target of $52.5.

Here are some recent targets:

• Richard Shane from JP Morgan set a target price of $48.0 on 01/12/2026
• Nicholas Holowko from UBS set a target price of $56.0 on 01/08/2026
• Moshe Orenbuch from TD Cowen set a target price of $55.0 on 01/08/2026
• John Pancari from Evercore ISI Group set a target price of $53.0 on 01/06/2026
• Jason Goldberg from Barclays set a target price of $54.0 on 01/05/2026
• David Smith from Truist Securities set a target price of $51.0 on 12/22/2025
• Donald Fandetti from Wells Fargo set a target price of $52.0 on 12/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$10,000 of ADIAL PHARMACEUTICALS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FDA issues related to Addiction"

You can find more data on corporate lobbying on Quiver Quantitative.

ADIL Hedge Fund Activity

We have seen 8 institutional investors add shares of ADIL stock to their portfolio, and 6 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITADEL ADVISORS LLC added 143,791 shares (+inf%) to their portfolio in Q3 2025, for an estimated $50,830
• VANGUARD GROUP INC added 142,865 shares (+1085.7%) to their portfolio in Q3 2025, for an estimated $50,502
• GEODE CAPITAL MANAGEMENT, LLC added 95,277 shares (+138.4%) to their portfolio in Q3 2025, for an estimated $33,680
• TWO SIGMA SECURITIES, LLC added 12,841 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,539
• JANE STREET GROUP, LLC removed 12,521 shares (-50.4%) from their portfolio in Q3 2025, for an estimated $4,426
• TWO SIGMA INVESTMENTS, LP removed 10,802 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,818
• PRIVATE MANAGEMENT GROUP INC added 10,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $3,535

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ADIL Analyst Ratings

Wall Street analysts have issued reports on $ADIL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Maxim Group issued a "Buy" rating on 09/30/2025

To track analyst ratings and price targets for ADIL, check out Quiver Quantitative's $ADIL forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of URBAN ONE INC. (FORMERLY KNOWN AS RADIO ONE INC.) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to radio broadcasting."

You can find more data on corporate lobbying on Quiver Quantitative.

UONEK Insider Trading Activity

UONEK insiders have traded $UONEK stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $UONEK stock by insiders over the last 6 months:

• TERRY L JONES has made 0 purchases and 4 sales selling 4,636 shares for an estimated $4,163.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UONEK Hedge Fund Activity

We have seen 8 institutional investors add shares of UONEK stock to their portfolio, and 14 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ZAZOVE ASSOCIATES LLC added 321,656 shares (+6.8%) to their portfolio in Q3 2025, for an estimated $223,840
• BARCLAYS PLC removed 217,196 shares (-21.7%) from their portfolio in Q3 2025, for an estimated $151,146
• DIMENSIONAL FUND ADVISORS LP removed 68,938 shares (-12.3%) from their portfolio in Q3 2025, for an estimated $47,973
• UBS GROUP AG added 63,483 shares (+220.7%) to their portfolio in Q3 2025, for an estimated $44,177
• MILLENNIUM MANAGEMENT LLC removed 21,743 shares (-19.8%) from their portfolio in Q3 2025, for an estimated $15,130
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 20,833 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $14,497
• CITADEL ADVISORS LLC removed 18,216 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,676

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of COMCAST CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to broadband; issues related to spectrum auction authority; issues related to privacy legislation issues related to utility pole access; issues related to AI policy; issues related to Congressional oversight of FCC Issues related to Name, Image, and Likeness (NIL) rights"

You can find more data on corporate lobbying on Quiver Quantitative.

CMCSA Congressional Stock Trading

Members of Congress have traded $CMCSA stock 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $CMCSA stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 12/18, 11/13, 08/14.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 0 purchases and 4 sales worth up to $60,000 on 11/18, 11/12, 10/09, 08/05.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
• REPRESENTATIVE SCOTT FRANKLIN has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CMCSA Hedge Fund Activity

We have seen 837 institutional investors add shares of CMCSA stock to their portfolio, and 1,267 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO removed 20,842,900 shares (-19.8%) from their portfolio in Q3 2025, for an estimated $654,883,918
• BLACKROCK, INC. added 19,581,123 shares (+6.5%) to their portfolio in Q3 2025, for an estimated $615,238,884
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 17,033,024 shares (+45.3%) to their portfolio in Q3 2025, for an estimated $535,177,614
• PRICE T ROWE ASSOCIATES INC /MD/ removed 13,186,740 shares (-37.3%) from their portfolio in Q3 2025, for an estimated $414,327,370
• CAPITAL WORLD INVESTORS removed 12,638,145 shares (-9.8%) from their portfolio in Q3 2025, for an estimated $397,090,515
• CAPITAL RESEARCH GLOBAL INVESTORS added 10,633,206 shares (+46.1%) to their portfolio in Q3 2025, for an estimated $334,095,332
• ALLIANCEBERNSTEIN L.P. removed 9,952,848 shares (-55.7%) from their portfolio in Q3 2025, for an estimated $312,718,484

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CMCSA Analyst Ratings

Wall Street analysts have issued reports on $CMCSA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• B of A Securities issued a "Buy" rating on 01/12/2026
• Benchmark issued a "Buy" rating on 01/06/2026
• Citigroup issued a "Buy" rating on 11/03/2025
• TD Cowen issued a "Buy" rating on 10/31/2025

To track analyst ratings and price targets for CMCSA, check out Quiver Quantitative's $CMCSA forecast page.

CMCSA Price Targets

Multiple analysts have issued price targets for $CMCSA recently. We have seen 15 analysts offer price targets for $CMCSA in the last 6 months, with a median target of $35.0.

Here are some recent targets:

• Laurent Yoon from Bernstein set a target price of $32.0 on 01/16/2026
• Kannan Venkateshwar from Barclays set a target price of $28.0 on 01/13/2026
• Jessica Reif Cohen from B of A Securities set a target price of $37.0 on 01/12/2026
• Matthew Harrigan from Benchmark set a target price of $44.0 on 01/06/2026
• Benjamin Swinburne from Morgan Stanley set a target price of $31.0 on 12/10/2025
• Barton Crockett from Rosenblatt set a target price of $30.0 on 12/01/2025
• Michael Ng from Goldman Sachs set a target price of $30.0 on 11/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of BIODESIX INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Medicare reimbursement for diagnostics. Medicare Contractor Reform. Lab test regulatory and reimbursement reform."

You can find more data on corporate lobbying on Quiver Quantitative.

BDSX Insider Trading Activity

BDSX insiders have traded $BDSX stock on the open market 19 times in the past 6 months. Of those trades, 4 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $BDSX stock by insiders over the last 6 months:

• JACK W SCHULER has made 4 purchases buying 3,648,790 shares for an estimated $2,611,422 and 0 sales.
• SCOTT HUTTON (President & CEO) has made 0 purchases and 3 sales selling 4,931 shares for an estimated $10,915.
• ROBIN HARPER COWIE (CFO, Sec'y & Treasurer) has made 0 purchases and 3 sales selling 1,336 shares for an estimated $3,220.
• KIERAN O'KANE (Chief Commercial Officer) has made 0 purchases and 3 sales selling 799 shares for an estimated $2,817.
• GARY ANTHONY PESTANO (Chief Development Officer) has made 0 purchases and 3 sales selling 763 shares for an estimated $2,787.
• CHRIS VAZQUEZ (Chief Accounting Officer) has made 0 purchases and 3 sales selling 324 shares for an estimated $870.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BDSX Hedge Fund Activity

We have seen 12 institutional investors add shares of BDSX stock to their portfolio, and 23 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• TELEMARK ASSET MANAGEMENT, LLC added 414,124 shares (+inf%) to their portfolio in Q3 2025, for an estimated $3,126,636
• ABERDEEN GROUP PLC added 262,425 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,784,490
• VANGUARD GROUP INC added 181,904 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,373,375
• MONASHEE INVESTMENT MANAGEMENT LLC removed 100,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $755,000
• SILVERARC CAPITAL MANAGEMENT, LLC removed 53,518 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $404,060
• PERKINS CAPITAL MANAGEMENT INC added 52,633 shares (+inf%) to their portfolio in Q3 2025, for an estimated $397,379
• GSA CAPITAL PARTNERS LLP added 48,342 shares (+inf%) to their portfolio in Q3 2025, for an estimated $364,982

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of ODYSSEY MARINE EXPLORATION INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Federal foreign policy and international governance issues related to offshore and seabed exploration activities, including U.S. engagement on international frameworks, coordination with foreign partners, and policy considerations affecting U.S. commercial access to and participation in international marine exploration and resource development. Federal defense and national security policy issues related to maritime domain awareness, seabed activity, and offshore operational considerations, including U.S. government perspectives on the strategic implications of deep-sea exploration activities. Federal trade and international commerce policy issues related to offshore and seabed exploration activities, including U.S. policy considerations affecting cross-border operations, equipment use, and international commercial participation in marine exploration and resource development. Federal policy and regulatory issues related to deep-sea exploration, maritime operations, and offshore research activities, including engagement on permitting frameworks, jurisdictional authorities, and U.S. policy considerations affecting commercial ocean exploration and recovery activities. Federal policy and regulatory issues related to offshore natural resources and seabed mineral exploration, including U.S. jurisdictional authorities, interagency coordination, and policy considerations affecting access to and development of marine mineral resources."

You can find more data on corporate lobbying on Quiver Quantitative.

OMEX Insider Trading Activity

OMEX insiders have traded $OMEX stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $OMEX stock by insiders over the last 6 months:

• JOHN D JR LONGLEY (President & COO) has made 0 purchases and 3 sales selling 256,049 shares for an estimated $944,928.
• MARK GORDON (Chief Executive Officer) has made 0 purchases and 3 sales selling 80,956 shares for an estimated $304,802.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

OMEX Hedge Fund Activity

We have seen 33 institutional investors add shares of OMEX stock to their portfolio, and 13 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• OLD WEST INVESTMENT MANAGEMENT, LLC added 3,676,882 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,169,919
• TWO SEAS CAPITAL LP added 3,139,242 shares (+219.4%) to their portfolio in Q3 2025, for an estimated $6,121,521
• GROUP ONE TRADING LLC added 625,445 shares (+808.4%) to their portfolio in Q3 2025, for an estimated $1,219,617
• RANGELEY CAPITAL, LLC added 479,478 shares (+inf%) to their portfolio in Q3 2025, for an estimated $934,982
• JEFFERIES FINANCIAL GROUP INC. added 400,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $780,000
• SLT HOLDINGS LLC added 277,750 shares (+inf%) to their portfolio in Q3 2025, for an estimated $541,612
• FOUNDATIONS INVESTMENT ADVISORS, LLC added 277,750 shares (+inf%) to their portfolio in Q3 2025, for an estimated $541,612

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$40,000 of METALLUS (FKA METTALLUS) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Defense manufacturing"

You can find more data on corporate lobbying on Quiver Quantitative.

MTUS Insider Trading Activity

MTUS insiders have traded $MTUS stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $MTUS stock by insiders over the last 6 months:

• MICHAEL S WILLIAMS (Chief Executive Officer) has made 0 purchases and 5 sales selling 33,937 shares for an estimated $648,716.
• NICHOLAS A YACOBOZZI (Chief Accounting Officer) sold 21,974 shares for an estimated $395,532
• KRISTOPHER R WESTBROOKS (President & COO) has made 0 purchases and 3 sales selling 15,025 shares for an estimated $293,248.
• KRISTINE C SYRVALIN (EVP General Counsel) sold 7,500 shares for an estimated $135,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MTUS Hedge Fund Activity

We have seen 87 institutional investors add shares of MTUS stock to their portfolio, and 83 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• INVENOMIC CAPITAL MANAGEMENT LP removed 697,815 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,534,881
• BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 326,788 shares (-74.1%) from their portfolio in Q3 2025, for an estimated $5,401,805
• BLACKROCK, INC. removed 297,037 shares (-4.3%) from their portfolio in Q3 2025, for an estimated $4,910,021
• CSM ADVISORS, LLC added 267,100 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,415,163
• GOLDMAN SACHS GROUP INC added 159,521 shares (+101.8%) to their portfolio in Q3 2025, for an estimated $2,636,882
• ROYCE & ASSOCIATES LP removed 143,658 shares (-14.6%) from their portfolio in Q3 2025, for an estimated $2,374,666
• ROYAL BANK OF CANADA removed 137,382 shares (-32.0%) from their portfolio in Q3 2025, for an estimated $2,270,924

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$370,000 of AECOM lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Appropriations for Defense and Military Construction for Fiscal Year 2026. Issues related to Base Realignment and Closure funding and policy. Issues related to Defense department contracting. Golden Dome program management. Issues related to Air Force facilities construction. Funding and policy for water resource investments. Appropriations to support Water Resources Development Act programs and projects. US Army Corps WIFIA program eligibility. US Army Corps Contracting issues. Investments and policy related to implementation of digital technologies in administration of environmental reviews and permitting. Funding and policy related to harmful algal bloom clean up. Issues related to federal facilities. Issues relating to international trade in engineering services. Issues related to U.S. Government international infrastructure development programs. Infrastructure projects in Latin America, Europe, Middle East. Disaster relief in Jamaica. FY 2026 Appropriations for Defense, Military Construction, Transportation HUD, Interior-EPA, Energy and Water, Homeland Security, and State, Foreign Operations. Funding, programs and projects pertaining to transportation and infrastructure investment, including funding for public transportation, rail and water, environmental programs and FEMA. Program requirements for the Department of State related to the ongoing conflict in Ukraine. Provisions related to harmful algal bloom mitigation. Provisions related to digital applications for NEPA environmental reviews and public engagement. Supplemental appropriations related to domestic disaster assistance. Funding for State Department infrastructure programs. Funding, programs and projects pertaining to transportation and infrastructure investment, including funding for aviation, highways, public transportation and rail. Issues related to train station improvements. Surface transportation authorization legislation. Legislation to support digital applications for NEPA environmental reviews and public engagement for the Federal Highway Administration, including HR 4621, Interactive Federal Review Act (H.R.4621/S.2319). Issues related to the digital delivery of 3D models of infrastructure project designs, including the SMART Infrastructure Act. Funding for FEMA and Disaster Relief efforts, including pre-disaster mitigation grants and Stafford Act policy. Supplemental appropriations for domestic disaster assistance. FEMA reform legislation, including H.R.4669, the FEMA Act of 2025. Flood mapping programs and legislation to reform the National Flood Insurance Program."

You can find more data on corporate lobbying on Quiver Quantitative.

ACM Insider Trading Activity

ACM insiders have traded $ACM stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $ACM stock by insiders over the last 6 months:

• TROY RUDD (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 2 sales selling 53,097 shares for an estimated $6,348,193.
• LARA POLONI (PRESIDENT) has made 0 purchases and 2 sales selling 17,533 shares for an estimated $1,701,134.
• DAVID Y. GAN (CHIEF LEGAL OFFICER) has made 0 purchases and 2 sales selling 15,502 shares for an estimated $1,514,889.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ACM Hedge Fund Activity

We have seen 299 institutional investors add shares of ACM stock to their portfolio, and 308 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ORION PORFOLIO SOLUTIONS, LLC removed 5,319,446 shares (-99.7%) from their portfolio in Q3 2025, for an estimated $694,028,119
• FIRST TRUST ADVISORS LP added 2,162,158 shares (+105.3%) to their portfolio in Q3 2025, for an estimated $282,096,754
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,086,071 shares (+78.8%) to their portfolio in Q3 2025, for an estimated $272,169,683
• AMUNDI removed 806,913 shares (-43.7%) from their portfolio in Q3 2025, for an estimated $105,277,939
• PRIMECAP MANAGEMENT CO/CA/ removed 684,889 shares (-7.2%) from their portfolio in Q3 2025, for an estimated $89,357,467
• UBS GROUP AG added 672,281 shares (+71.3%) to their portfolio in Q3 2025, for an estimated $87,712,502
• INVESCO LTD. added 618,205 shares (+14.2%) to their portfolio in Q3 2025, for an estimated $80,657,206

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ACM Analyst Ratings

Wall Street analysts have issued reports on $ACM in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 01/21/2026
• Truist Securities issued a "Buy" rating on 11/21/2025
• RBC Capital issued a "Outperform" rating on 11/20/2025
• Argus Research issued a "Buy" rating on 11/20/2025
• Barclays issued a "Overweight" rating on 11/20/2025
• Citigroup issued a "Buy" rating on 11/19/2025
• B of A Securities issued a "Buy" rating on 08/05/2025

To track analyst ratings and price targets for ACM, check out Quiver Quantitative's $ACM forecast page.

ACM Price Targets

Multiple analysts have issued price targets for $ACM recently. We have seen 9 analysts offer price targets for $ACM in the last 6 months, with a median target of $139.0.

Here are some recent targets:

• Steven Fisher from UBS set a target price of $143.0 on 01/21/2026
• Adam Seiden from Barclays set a target price of $100.0 on 12/22/2025
• Jamie Cook from Truist Securities set a target price of $126.0 on 12/18/2025
• Andrew Wittmann from Baird set a target price of $143.0 on 11/21/2025
• John Staszak from Argus Research set a target price of $135.0 on 11/20/2025
• Sabahat Khan from RBC Capital set a target price of $139.0 on 11/20/2025
• Andrew Kaplowitz from Citigroup set a target price of $152.0 on 11/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$45,000 of VIRTU FINANCIAL LLC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to market making and asset management Issues related to market making and asset mangement Issued related to market making and derivatives"

You can find more data on corporate lobbying on Quiver Quantitative.

VIRT Insider Trading Activity

VIRT insiders have traded $VIRT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $VIRT stock by insiders over the last 6 months:

• BRETT FAIRCLOUGH (Co-President & Co-COO) sold 90,701 shares for an estimated $3,846,048
• VIRGINIA GAMBALE sold 3,875 shares for an estimated $133,958

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

VIRT Hedge Fund Activity

We have seen 207 institutional investors add shares of VIRT stock to their portfolio, and 212 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• INVESCO LTD. added 926,376 shares (+64.2%) to their portfolio in Q3 2025, for an estimated $32,886,348
• BALYASNY ASSET MANAGEMENT L.P. removed 580,832 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $20,619,536
• FREESTONE GROVE PARTNERS LP added 538,083 shares (+inf%) to their portfolio in Q3 2025, for an estimated $19,101,946
• QUBE RESEARCH & TECHNOLOGIES LTD added 474,177 shares (+53.1%) to their portfolio in Q3 2025, for an estimated $16,833,283
• FMR LLC removed 449,810 shares (-9.9%) from their portfolio in Q3 2025, for an estimated $15,968,255
• D. E. SHAW & CO., INC. added 448,411 shares (+106.5%) to their portfolio in Q3 2025, for an estimated $15,918,590
• PRUDENTIAL FINANCIAL INC added 391,895 shares (+406.6%) to their portfolio in Q3 2025, for an estimated $13,912,272

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

VIRT Price Targets

Multiple analysts have issued price targets for $VIRT recently. We have seen 3 analysts offer price targets for $VIRT in the last 6 months, with a median target of $45.0.

Here are some recent targets:

• Patrick Moley from Piper Sandler set a target price of $54.0 on 01/14/2026
• Alexander Blostein from Goldman Sachs set a target price of $38.0 on 10/06/2025
• Alex Kramm from UBS set a target price of $45.0 on 08/04/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.